Closure device and methods for making and using them

Information

  • Patent Grant
  • 9320522
  • Patent Number
    9,320,522
  • Date Filed
    Wednesday, August 31, 2011
    13 years ago
  • Date Issued
    Tuesday, April 26, 2016
    8 years ago
Abstract
A clip for engaging tissue includes a generally annular-shaped body defining a plane and disposed about a central axis extending normal to the plane. The body includes alternating inner and outer curved regions, defining a zigzag pattern about a periphery of the clip. The body is biased towards a planar configuration lying in the plane and deflectable towards a transverse configuration extending out of the plane. Tines extend from the inner curved regions, the tines being oriented towards the central axis in the planar configuration, and parallel to the central axis in the transverse configuration. The tines may include primary tines and secondary tines that are shorter than the primary tines. The primary tines may be disposed on opposing inner curved regions and oriented towards one another such that they overlap in the planar configuration.
Description
FIELD OF THE INVENTION

The present invention relates generally to apparatus and methods for engaging tissue and/or closing openings through tissue, and more particularly to devices for closing a puncture in a blood vessel or other body lumen formed during a diagnostic or therapeutic procedure, and to methods for making and using such devices.


BACKGROUND

Catheterization and interventional procedures, such as angioplasty or stenting, generally are performed by inserting a hollow needle through a patient's skin and intervening tissue into the vascular system. A guide wire may then be passed through the needle lumen into the patient's blood vessel accessed by the needle. The needle may be removed, and an introducer sheath may be advanced over the guide wire into the vessel, e.g., in conjunction with or subsequent to a dilator. A catheter or other device may then be advanced through a lumen of the introducer sheath and over the guide wire into a position for performing a medical procedure. Thus, the introducer sheath may facilitate introducing various devices into the vessel, while minimizing trauma to the vessel wall and/or minimizing blood loss during a procedure.


Upon completing the procedure, the devices and introducer sheath may be removed, leaving a puncture site in the vessel wall. External pressure may be applied to the puncture site until clotting and wound sealing occur. This procedure, however, may be time consuming and expensive, requiring as much as an hour of a physician's or nurse's time. It is also uncomfortable for the patient, and requires that the patient remain immobilized in the operating room, catheter lab, or holding area. In addition, a risk of hematoma exists from bleeding before hemostasis occurs.


Various apparatus have been suggested for percutaneously sealing a vascular puncture by occluding the puncture site. For example, U.S. Pat. Nos. 5,192,302 and 5,222,974, issued to Kensey et al., describe the use of a biodegradable plug that may be delivered through an introducer sheath into a puncture site. When deployed, the plug may seal the vessel and provide hemostasis. Such devices, however, may be difficult to position properly with respect to the vessel, which may be particularly significant since it is generally undesirable to expose the plug material, e.g., collagen, within the bloodstream, where it may float downstream and risk causing an embolism.


Another technique has been suggested that involves percutaneously suturing the puncture site, such as that disclosed in U.S. Pat. No. 5,304,184, issued to Hathaway et al. Percutaneous suturing devices, however, may require significant skill by the user, and may be mechanically complex and expensive to manufacture.


U.S. Pat. No. 5,478,354, issued to Tovey et al., discloses a surgical fastener including an annular base having legs that, in a relaxed state, extend in a direction substantially perpendicular to a plane defined by the base and slightly inwards toward one another. During use, the fastener is fit around the outside of a cannula, thereby deflecting the legs outward. The cannula is placed in an incision, and the fastener is slid along the cannula until the legs pierce into skin tissue. When the cannula is withdrawn, the legs move towards one another back to the relaxed state to close the incision.


U.S. Pat. Nos. 5,007,921 and 5,026,390, issued to Brown, disclose staples that may be used to close a wound or incision. In one embodiment, an “S” shaped staple is disclosed that includes barbs that may be engaged into tissue on either side of the wound. In another embodiment, a ring-shaped staple is disclosed that includes barbs that project from the ring. Sides of the ring may be squeezed to separate the barbs further, and the barbs may be engaged into tissue on either side of a wound. The sides may then be released, causing the barbs to return closer together, and thereby pulling the tissue closed over the wound. These staples, however, have a large cross-sectional profile and therefore may not be easy to deliver through a percutaneous site to close an opening in a vessel wall.


Accordingly, devices for engaging tissue, e.g., to close a vascular puncture site, would be considered useful.


SUMMARY OF THE INVENTION

The present invention is directed to devices and methods for engaging tissue, e.g., to connect tissue segments together or to close and/or seal openings through tissue, such as in a wall of a body lumen. More particularly, the present invention is directed to vascular closure devices or clips for closing a puncture in a wall of a blood vessel formed during a diagnostic or therapeutic procedure, and to methods for making and using such devices.


In one aspect of the present invention, a device for engaging tissue includes a generally annular-shaped body defining a plane and disposed about a central axis extending substantially normal to the plane. The body may be movable from a substantially planar configuration lying generally in the plane towards a transverse configuration extending out of the plane. The body may also include a plurality of looped elements including alternating first and second curved regions that define an inner and outer periphery of the body, respectively, in the planar configuration. A plurality of tines or other tissue-engaging elements may extend from the first curved regions, and may be oriented towards the central axis in the planar configuration, and substantially parallel to the central axis in the transverse configuration. The device may be biased towards the planar configuration, e.g., to bias the tines towards the central axis.


The looped elements of the device may generally define an endless zigzag pattern, e.g., a sinusoidal pattern, extending about the central axis. The looped elements may facilitating deforming the device between the planar and transverse configurations, e.g., by distributing stresses through the device and minimizing localized stresses in the curved regions. In addition, the looped elements may be expandable between expanded and compressed states for increasing and reducing a periphery of the body in the transverse orientation, respectively. The looped elements may be biased towards one of the compressed and expanded states.


Adjacent tines of the device may have a first curved region disposed between them. The first curved region between adjacent tines may include a substantially blunt element extending towards the central axis. The blunt element may have a length shorter than lengths of the adjacent tines.


In addition or alternatively, the tines of the device may include first and second primary tines, having a first length and a second length, respectively, which may be the same as or different than one another. The first and second primary tines may be disposed on opposing first curved regions, and may be oriented substantially towards each other in the planar configuration. In the planar configuration, the first and second primary tines may at least partially overlap. The tines may also include one or more secondary tines having a length substantially shorter than the first and second lengths of the primary tines. The secondary tines may be disposed on either side of the first and second primary tines.


In another aspect of the present invention, a device for engaging tissue includes a generally annular-shaped body defining a plane and disposed about a central axis extending substantially normal to the plane. The body may be movable from a substantially planar configuration lying generally in the plane towards a transverse configuration extending out of the plane. A first primary tine, having a first length, may extend from the body towards the central axis in the planar configuration, and may be deflectable out of the plane when the body is moved towards the transverse configuration. A second primary tine, having a second length, may extend from the body towards the first tine when the body is in the planar configuration, and may be deflectable out of the plane when the body is moved towards the transverse configuration. The lengths of the first and second primary tines may cause the primary tines to at least partially overlap in the planar configuration. The body may be biased towards the planar configuration to bias the tines generally towards the central axis.


The device may include a set of secondary tines having a length shorter than the first and second lengths. The secondary tines may extend from the body towards the central axis in the planar configuration, and may be deflectable out of the plane when the body is moved towards the transverse configuration. In an exemplary embodiment, a secondary tine may be disposed on either side of the first primary tine, and a secondary tine may be disposed on either side of the second primary tine.


Optionally, adjacent tines may have a first curved region disposed between them. The first curved region between adjacent tines may include a substantially blunt element extending towards the central axis. The blunt element may have a length shorter than lengths of the adjacent tines.


Also, the device may include a plurality of looped elements disposed around a periphery of the body. The looped elements may generally define an endless zigzag pattern extending about the central axis. The first primary tine and the second primary tine may extend from looped elements disposed opposite one another. The looped elements may be expandable between expanded and compressed states for increasing and reducing a periphery of the body in the transverse orientation, respectively. The looped elements may be biased towards one of the compressed and expanded states.


In another aspect of the present invention, a method is provided for manufacturing a clip from an elastic material, such as a sheet of superelastic alloy, e.g., a nickel-titanium alloy (“Nitinol”). The components of the clip, e.g., a generally-annular body, optionally including looped elements, and/or tines, may be formed by removing portions from the sheet. The portions may be removed, e.g., by laser cutting, chemical etching, photo chemical etching, stamping, electrical discharge machining, and the like. The clip may be polished using one or more processes, such as electro-polishing, chemical etching, tumbling, sandblasting, sanding, and the like, and/or heat-treated to provide a desired finish and/or desired mechanical properties. Optionally, the body and tines may be coated with a therapeutic agent, e.g., a peptide coating and/or one or more clotting factors.


In addition or alternatively, the clip may be disposed in a planar configuration, e.g., upon forming the clip from the sheet, and heat treated to form a clip biased to the planar configuration. For example, the clip may be formed from a shape memory material, e.g., Nitinol, that may substantially recover the planar configuration when heated to a first predetermined temperature corresponding to an austenitic state, e.g., a temperature close to body temperature. The clip may be cooled to a second predetermined temperature corresponding to a martensitic state, e.g., a temperature at or below ambient temperature, and malleably manipulated.


For example, the clip formed from the sheet may be deformed to a transverse configuration, such as that described above, e.g., by loading the clip onto a mandrel or directly onto a delivery device. If the clip includes looped elements formed from the body, the looped elements may be biased upon heat treatment towards an expanded state, but may be malleably deformed to a compressed state upon cooling, e.g., to facilitate loading onto the delivery device. Alternatively, the clip may be formed from a superelastic material, e.g., Nitinol, such that the clip may be resiliently deformed to the transverse configuration and/or compressed state, yet may automatically attempt to resume its planar configuration and/or expanded state upon release from external forces.


In still another aspect of the present invention, a method for closing an opening in a wall of a body lumen is provided. The distal end of an elongate member may be advanced through an opening in a patient's skin, along a passage through tissue, and into the body lumen. A distal portion of an obturator may be positioned distally beyond the distal end of the elongate member along the passage within the body lumen. One or more expandable elements on the distal portion of the obturator may be expanded transversely. The obturator may be withdrawn from the passage until the expandable elements contact the wall of the body lumen, thereby providing a tactile indication of a location of the wall of the body lumen between the elongate member and the plurality of expandable elements of the obturator.


A clip may be advanced into the passage over the elongate member until tines of the clip penetrate the wall of the body lumen, the tines and the expandable elements on the obturator being angularly offset from one another such that the tines penetrate the wall at locations between the expandable elements. The obturator may be collapsed, and the elongate member and/or obturator may be withdrawn from the body lumen and passage, leaving the clip to substantially close the opening in the wall of the body lumen. When the elongate member is withdrawn, the tines may automatically at least partially move towards a planar configuration to substantially close the opening.


The tines of the clip may include primary tines and secondary tines. Here, advancing the clip may include puncturing the wall of the body lumen with the primary tines until tips of the primary tines enter the body lumen, and puncturing the wall of the body lumen with the secondary tines. The primary tines and the secondary tines may puncture the walls without contacting the expandable elements of the obturator.


Other objects and features of the present invention will become apparent from consideration of the following description taken in conjunction with the accompanying drawings.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1A is a top view of a first embodiment of a clip including a plurality of tines in a planar orientation, in accordance with the present invention.



FIGS. 1B and 1C are side views of the clip of FIG. 1A, with the tines oriented substantially transversely from the planar orientation, in compressed and expanded states, respectively.



FIG. 2A is a top view of a second embodiment of a clip including a plurality of tines in a planar orientation, in accordance with the present invention.



FIGS. 2B and 2C are side views of the clip of FIG. 2A, with the tines oriented substantially transversely from the planar orientation, in compressed and expanded states, respectively.



FIG. 3 is a top view of a third embodiment of a clip, in accordance with the present invention.



FIG. 4 is a top view of an embodiment of a clip having radiopaque markers thereon.



FIG. 5 is a top view of an embodiment of a clip having pockets for holding radiopaque markers therein.



FIG. 6 is a top view of another embodiment of a clip including stop elements, in accordance with the present invention.



FIG. 7 is a top view of yet another embodiment of a clip including stop elements, in accordance with the present invention.



FIG. 8 is a top view of still another embodiment of a clip including stop elements, in accordance with the present invention.



FIG. 9 is a side view of an apparatus, including an introducer sheath and an obturator, suitable for delivering a clip of the present invention.



FIGS. 10A-10D are cross-sectional views of a blood vessel, showing a method for delivering a clip into a passage communicating with the vessel using the apparatus of FIG. 9.



FIG. 11A is a top view of the blood vessel of FIGS. 10A-10D, showing the orientation of the expandable elements of the obturator and openings produced by primary tines of the clip relative to an arteriotomy in the vessel.



FIG. 11B is a top view of the blood vessel of FIG. 11A, showing the arteriotomy being closed by the clip.



FIG. 12 is a top view of an embodiment of a clip having arcuate tines, in accordance with the present invention.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

Turning now to the drawings, FIGS. 1A-1C show a first preferred embodiment of a closure device or clip 10 for closing an incision, puncture, or other passage through tissue, e.g., communicating with a blood vessel or other body lumen (not shown). The clip 10 includes a body 12, which may be generally annular in shape and surrounds a central axis 24, and a plurality of tines 16 extending from the body 12. As used herein, an “annular-shaped body” includes any hollow body, e.g., including one or more structures surrounding an opening, whether the body is substantially flat or has a significant thickness or depth. Thus, although an annular-shaped body may be circular, it may include other noncircular shapes as well, such as elliptical or other shapes that are asymmetrical about a central axis.


The body 12 may include a plurality of looped or curved elements 30 that are connected to one another to form the body 12. Each looped element 30 may include an inner or first curved region 32 and an outer or second curved region 34. In a preferred embodiment, the first and second curved regions 32, 34 are out of phase with one another and are connected alternately to one another, thereby defining an endless sinusoidal or serpentine pattern. Alternatively, other generally zigzag patterns may be provided that repeat periodically, e.g., saw tooth or square tooth patterns (not shown), instead of a sinusoidal pattern, thereby defining inner and outer regions that alternate about the body 12. When the clip 10 is in a substantially planar configuration, as shown in FIG. 1A, the first curved regions 32 may define an inner periphery 36 of the body 12 and the clip 10, and the second curved regions 34 may define an outer periphery 38.


The plurality of tines 16 may be biased to extend generally inwardly, e.g., towards one another and/or towards the central axis 24. The tines 16 may be disposed on the first curved regions 32, and oriented toward the central axis 24 when the clip 10 is in the planar configuration. In a preferred embodiment, the tines 16 may be provided in pairs opposite from one another or provided otherwise symmetrically with respect to the central axis 24.


The tines 16 may include a variety of pointed tips, such as a bayonet tip, and/or may include barbs (not shown) for penetrating or otherwise engaging tissue. For example, to increase the penetration ability of the clip 10 and/or to lower the insertion force required to penetrate tissue, each tine 16 may include a tapered edge (not shown) extending towards the tip along one side of the tine 16. Alternatively, each tine 16 may be provided with a tapered edge on each side of the tine 16 extending towards the tip.


Additionally, as shown in FIGS. 1A-1C, the tines 16 may be disposed on alternating first curved regions 32. Thus, at least one period of a zigzag pattern may be disposed between adjacent tines 16, which may enhance flexibility of the clip 10, as explained further below.


As shown in FIGS. 1B and 1C (where opposite ends 33a, 33b are connected to one another), the body 12 and/or the tines 16 may be deflected such that the tines 16 extend transversely with respect to the plane defined in the planar configuration, thereby defining a transverse configuration for the clip 10. Preferably, the tines 16 are oriented substantially parallel to the central axis 24 in the transverse configuration, as shown in FIG. 1B. In the transverse configuration, the body 12 may have a generally annular shape defining a length, L1, that extends generally parallel to the central axis 24, and corresponds generally to an amplitude of the zigzag pattern. Preferably, the body 12 is sufficiently flexible such that the clip 10 may assume a generally circular or elliptical shape (not shown), e.g., conforming to an exterior surface of a delivery device (not shown) used to deliver the clip 10.


In a preferred embodiment, the tines 16 and/or body 12 are biased to move from the transverse configuration towards the planar configuration of FIG. 1A. Thus, with the tines 16 in the transverse configuration, the tines 16 may penetrate and/or be engaged with tissue at a puncture site. When the clip 10 is released, the tines 16 may attempt to return towards one another as the clip 10 moves towards the planar configuration, thereby drawing the engaged tissue together and substantially closing and/or sealing the puncture site, as explained further below.


The looped elements 30 may distribute stresses in the clip 10 as it is deformed between the planar and transverse configurations, thereby minimizing localized stresses that may otherwise plastically deform, break, or otherwise damage the clip 10 during delivery. In addition, when the clip 10 is in the transverse configuration, the looped elements 30 may be movable between a compressed state, such as that shown in FIG. 1B, and an expanded state, such as that shown in FIG. 1C. Preferably, the looped elements 30 are biased towards the expanded state, but may be compressed to the compressed state, e.g., by constraining the clip 10. Alternatively, only a portion of the looped elements 30 may be biased towards the expanded state, e.g., the first curved regions 32, and/or the looped elements 30 may be biased towards the compressed state. Furthermore, the looped elements 30 reduce the force required to be exerted on the clip 10 to transition the clip 10 from the planar configuration to the transverse configuration before loading onto a delivery device (not shown).


With the clip 10 in the transverse configuration, the looped elements 30 may be circumferentially and/or radially compressed to the compressed state until the clip 10 defines a first diameter or circumference 26a, such as that shown in FIG. 1B. The clip 10 may be constrained in the compressed state, e.g., by loading the clip 10 onto a carrier assembly of a delivery device (not shown), as described further below. When released from the constraint, e.g., when deployed from the carrier assembly, the clip 10 may automatically expand towards the expanded state, such as that shown in FIG. 1C, thereby defining a second diameter or circumference 26b. Thus, the looped elements 30 may facilitate reducing the profile of the clip 10 during delivery, e.g., to facilitate introducing the clip 10 through a smaller puncture or passage. Once the clip 10 is deployed entirely from the delivery device, the looped elements 30 may resiliently expand as the clip 10 returns towards the planar configuration, as explained further below.


To manufacture the clip 10 (or, similarly, any of the other clips described herein), the body 12 and the tines 16 may be integrally formed from a single sheet of material, e.g., a superelastic alloy, such as a nickel-titanium alloy (“Nitinol”). Portions of the sheet may be removed using conventional methods, such as laser cutting, chemical etching, photo chemical etching, stamping, using an electrical discharge machine (EDM), and the like, to form the clip. The tines 16 may be sharpened to a point, i.e., tips may be formed on the tines 16 using conventional methods, such as chemical etching, mechanical grinding, and the like.


The clip 10 may be polished to a desired finish using conventional methods, such as electro-polishing, chemical etching, tumbling, sandblasting, sanding, and the like. Polishing may perform various functions depending on the method used to form the clip 10. For a clip formed by laser cutting or using an EDM, polishing may remove heat affected zones (HAZ) and/or burrs from the clip. For a clip formed by photo chemical etching, polishing may create a smoother surface finish. For a clip formed by stamping, polishing may remove or reduce burrs from the bottom side of the clip, and/or may smooth the “roll” that may result on the topside of the clip from the stamping process.


In addition or alternatively, the clip 10 may be formed from a shape memory alloy, e.g., Nitinol, with the looped elements 30 formed initially in the compressed state and/or the clip 10 in the planar configuration. With the clip 10 deformed to the transverse configuration, the clip 10 may be expanded, e.g., by applying a force radially outwards against an inner surface of the clip 10, thereby expanding the looped elements 30 to the expanded state. The looped elements 30 may then be heat treated, e.g., by heating the clip 10 to an austenitic state, to cause the looped elements 30 to “remember” the expanded state, as is known to those skilled in the art. It may also be necessary to further heat treat the clip 10 further, e.g., with the tines in the planar configuration to cause the body 12 and/or tines 16 to “remember” and be biased towards the planar configuration, as is known to those skilled in the art. The clip 10 may then be cooled, e.g., to a martensitic state, which may be at or close to ambient temperature, and manipulated, e.g., malleably deformed to the transverse configuration, for example, by loading the clip 10 onto a delivery device (not shown), as described below. Thus, if the clip 10 is subsequently heated to a predetermined temperature, e.g., at or below body temperature, the material may remember the planar configuration and/or expanded state and become biased towards them.



FIGS. 2A-2C show another preferred embodiment of a closure device or clip 110 that includes a generally annular-shaped body 112 defining a plane and disposed about a central axis 124 extending through the plane. The body 112 preferably includes a plurality of looped elements 130 that are connected to one another to form the body 112, similar to the previous embodiment. Each looped element 130 includes an inner or first curved region 132 and an outer or second curved region 134. Similar to the previous embodiment, the first and second curved regions 132, 134 may form an endless sinusoidal pattern or other generally zigzag pattern. When the clip 110 is in a substantially planar configuration, as shown in FIG. 2A, the first curved regions 132 may define an inner periphery 136, and the second curved regions 134 may define an outer periphery.


Unlike the previous embodiment, the clip 110 includes a plurality of primary tines 114 and a plurality of secondary tines 116. Each of the primary and secondary tines 114, 116 may include a variety of known pointed tips, similar to the previous embodiment.


Each of the primary tines 114 may have a length l1, although alternatively each of the primary tines 114 may have a different length than one another. The primary tines 114 may be disposed in one or more opposing pairs, e.g., on opposing first curved regions 132, and may be oriented towards and/or across the central axis 124 in the planar configuration. In the planar configuration, the lengths l1 may be sufficiently long such that the primary tines 114 at least partially overlap one another, i.e., extend across the central axis 124 towards an opposing tine 114. Therefore, the tips of the primary tines 114 may extend past the central axis 124 and/or the primary tines 114 in each pair may lie substantially parallel to each other when the clip 110 is in the planar configuration.


Each of the secondary tines 116 may be disposed on a first or inner curved region 132, e.g., such that one or more secondary tines 116 may be provided between opposing pairs of primary tines 114. Each of the secondary tines 116 may have a length l2 that is substantially less than the length l1 of the primary tines 114.


Preferably, a secondary tine 116 is disposed on either side of each primary tine 114. For example, the clip 110 shown in FIGS. 2A-2C has first and second primary tines 114, and each of the first and second primary tines 114 has a secondary tine 116 on either side of it. Thus, the clip 110 may have a total of two primary tines 114 and four secondary tines 116. Optionally, the secondary tines 116 may be disposed substantially symmetrically about the central axis 124. The tines 114, 116 may be provided on every other first curved regions 132. For example, a first curved region 132 having neither a primary tine 114 nor a secondary tine 116 may separate each adjacent tine, e.g., between two adjacent secondary tines 116, or between a secondary tine 116 and a primary tine 114.


As shown in FIGS. 2B and 2C, the body 112 and/or the tines 114, 116 may be deflected such that they extend transversely with respect to the plane defined in FIG. 2A. Preferably, the primary tines 114 and secondary tines 116 are oriented substantially parallel to the central axis 124 to define a transverse configuration, as shown in FIG. 1B. In the transverse configuration, the body 112 has a generally annular shape defining a length, LE1, that extends generally parallel to the central axis 24, and corresponds generally to an amplitude of the sinusoidal pattern. Preferably, the body 112 is sufficiently flexible such that the clip 110 may assume a generally circular or elliptical shape (not shown), e.g., conforming to an exterior surface of a delivery device (not shown).


The tines 114, 116 may be biased towards one another and/or towards the central axis 124, i.e., due to the bias of the clip 110 towards the planar configuration of FIG. 2A, similar to the previous embodiment. With the clip 110 in the transverse configuration, the clip 110 may be delivered such that the primary tines 114 entirely penetrate the wall of a blood vessel or other body lumen, while the secondary tines 116 only partially penetrate the wall due to their relative lengths, as explained further below.


The looped elements 130 may be expandable between a compressed state, as shown in FIG. 2B, and an expanded state, as shown in FIG. 2C, similar to the previous embodiment. Preferably, the looped elements 130 are biased to the expanded state, but may be resiliently compressed to the compressed state, e.g., by constraining the clip 110.


Turning to FIG. 3, an alternative embodiment of a clip 210 is shown that includes a body 112 including looped elements 130, and primary tines 114, similar to the previous embodiment, but has no supplemental or secondary tines 116. The reference numbers for elements of the clip 210 are consistent with like elements used for the clip 110.


Any of the clips of the present invention may include one or more radiopaque markers or other markers visible using external imaging, such as fluoroscopy. For example, using the clip 110 of FIGS. 2A-2C as an example, the entire clip 110 may be coated with radiopaque material, which may be a high density material such as gold, platinum, platinum/iridium, and the like.


Alternatively, the clip 110 may be partially coated with radiopaque material by using masking techniques. For example, the entire clip 110 may first be coated with radiopaque material. The clip 110 may then be masked at locations where the radiopaque coating is desired. For example, the looped elements 130 of the clip 110 may be left unmasked during this process if it is desired to leave the looped elements 130 uncoated by radiopaque material. This may be desirable, e.g., to prevent radiopaque material from adversely affecting the flexibility of the looped elements 130. The clip 110 may then be treated to remove the radiopaque material from the unmasked areas, in this example, the looped elements 130. The masking may then be removed using conventional processes, leaving the rest of the clip 110 coated with radiopaque material.


Turning to FIG. 4, in another alternative, one or more discrete markers 102 may be provided at predetermined locations on the clip 110. For example, high density or radiopaque material 102 may be crimped or otherwise secured onto opposing double looped or circular regions 130. In another embodiment, shown in FIG. 5, a plurality of pockets 104 may be provided on the looped elements 130 into which high density plugs (not shown) may be bonded or otherwise secured. These various radiopaque markers may also be incorporated in any of the embodiments described herein.


Turning to FIG. 6, another embodiment of a clip 310 is shown that, similar to clip 110, may include a plurality of looped elements 330 that interconnect to form a body 312. Each looped element 330 may have a first or inner curved region 332 and a second or outer curved region 334. Primary tines 314 may be disposed on opposing first curved regions 332, which, optionally, may include a barb 302 thereon to enhance engagement with tissue. Secondary tines 316 may be provided on first curved regions 332 on either side of each primary tine 314. In addition, a first curved region 332 without a tine 314, 316 may separate adjacent tines, as described above with regard to the previous embodiments.


The clip 310 also includes stop members 306 on one or more of the tines 314, 316, e.g., adjacent the respective first curved region 332. Each stop member 306 may be blunt-shaped, e.g., generally triangularly with an apex 307 of the stop member 306 extending from the first curved region 332, and the tine 314, 316 extending from a wide or blunt base 307 of the stop member 306. During use, the blunt bases 307 may limit penetration of the respective tines 314, 316 into tissue by reducing an effective length of the respective tine 314, 316. For example, when the tines 314, 316 are driven into tissue, the tines 314, 316 may penetrate the tissue until the blunt bases 307 contact the tissue, whereupon the tines 314, 316 may be prevented from penetrating further into the tissue.


Turning to FIG. 7, another embodiment of a clip 410(i) is shown that includes a body 412, a plurality of tines 414, and a plurality of spring elements 440(i) that interconnect between adjacent tines 414. The body 412 includes outer curved regions 434 that extend between adjacent tines 414, thereby defining an outer periphery for the clip 410(i). The clip 410(i) may be moveable between a substantially planar configuration such as that shown in FIG. 7, and a transverse configuration (not shown), and preferably is biased towards the planar configuration, similar to the previous embodiments.


In the embodiment shown, the spring elements 440(i) generally are hollow diamond shaped elements, including curved inner regions 432(i) oriented towards the central axis 424 of the body 412 when the clip 410(i) is in the planar configuration. The spring elements 440(i) may serve multiple purposes. First, the spring elements 440(i) may bias the clip 410(i), e.g., allowing the clip 410(i) to at least partially expand resiliently. For example, when the clip 410(i) is deflected into the transverse configuration (not shown), the spring elements 440(i) may allow the tines 414 to be moved away from the central axis 424 and/or one another. Thus, during deployment, the tines 414 may be deflected radially outwardly or otherwise expanded to engage a larger area of tissue.


As the tines 414 are expanded, the spring elements 414(i) may deform to become wider (along a dimension extending generally between the adjacent tines 414) and shorter (along a dimension extending generally parallel to the tines 414). Once a force causing the tines 414 to expand is removed, the spring elements 414(i) may resiliently try to return towards their original shape, thereby pulling the tines 414 closer towards one another.


In addition, the curved inner regions 432(i) of the spring elements 414(i) may provide stops limiting penetration of the tines 414 into tissue, similar to the stop members described above. For example, when the clip 410(i) is in the transverse configuration and the spring elements 414(i) are expanded, the curved inner regions 432(i) may be become more oblique, possibly becoming generally linear. Thus, when the tines 414 are driven into tissue, the curved inner regions 432(i) may limit penetration of the tines 414.


Finally, after the clip 410(i) is deployed, e.g., the tines 414 are penetrated into tissue, the curved inner regions 432(i) may return towards their original shape, and may pinch or otherwise engage tissue between the inner curved regions 432(i) and the adjacent tines 414. Thus, contracting the spring elements 440(i) may enhance the ability of the clip 410(i) to seal a puncture site, e.g., by pulling engaged tissue inwardly towards the central axis 424 of the clip 410(i).


Turning to FIG. 8, an alternative embodiment of a clip 410(ii) is shown that is substantially similar to the clip 410(i) shown in FIG. 7, with the exception of the shape of the spring elements 440(ii). Rather than diamond shaped elements, the spring elements 440(ii) are looped elements generally defining a circular shape.


Turning now to FIG. 12, another preferred embodiment of a clip 710 of the present invention is illustrated. Similar to the previous embodiments, the clip 710 includes a generally annular-shaped body 712 that defines a plane. The body 712 is disposed about a central axis 724 that extends through the plane. The body 712 preferably includes a plurality of outer curved elements 730 that extend between adjacent tines 716 and are connected to each other to form the body 712. When the clip 710 is in a substantially planar configuration, as shown in FIG. 12, the curved elements 730 define an outer periphery 738 of the clip 710.


The tines 716 are curved or arcuately shaped and include distal tips 715 that extend toward the central axis 724 when the clip 710 is in the substantially planar configuration. Optionally, one or more of the tines 716 may include barbs 717, similar to the previous embodiments. Preferably, the curve of the tines 716 are all in phase with one another such that the tines 716 spiral about the central axis 724. This may allow a length of the tines 716 to be maximized for a given diameter of the body 712.


For example, the tines 716 may have a length that is greater than a radius of the body 712 without the distal tips 715 of the tines 716 touching one another. Thus, due to the arcuate shape of each tine 716, the tines 716 of clip 710 may be generally longer than the straight tines of the previous clips having comparable diameters. The tines 716 may, therefore, penetrate deeper into tissue than the tines of the other clips.


As with the previous embodiments, the body 712 and/or the tines 716 of clip 710 may be deflected until the tines 716 extend transversely with respect to the plane defined in the planar configuration, thereby defining a transverse configuration. In the transverse configuration, the tines 716 may be oriented substantially parallel to the central axis 724. Additionally, as with the previous embodiments, the tines 716 and/or body 712 may be biased to move from the transverse configuration towards the planar configuration. The clip 710 may be delivered in substantially the same manner as will be described with respect to other clips of the present invention.


Any of the clips of the present invention may be coated with a substance that enhances hemostasis and/or healing of a blood vessel, e.g., by increasing a rate of regeneration of endothelium on the interior surface of the vessel, or by decreasing inflammatory response at the treatment site. In one embodiment, a suitable synthetic peptide coating may be applied to a clip to attract endothelial cells to the surface. An exemplary synthetic peptide coating may, for example, attach to the same cell binding sites as collagen. In another embodiment, a clip may be coated with a combination of clotting factors in order to promote hemostasis. For example, one side of the clip may be coated with Factor III and an endopeptidase, such as PTA, to accelerate the intrinsic clotting pathway. On the opposite side of the clip, a combination of a protein cofactor proaccelerin (Factor V) and an activated endopeptidase, such as serum prothrombin conversion accelerator (SPCA), cothromboplastin, and the like, may be applied to accelerate the extrinsic clotting pathway. The clips of the present invention may also be coated with any suitable hydrophilic polymer that swells in the presence of bodily fluids in order to reduce, minimize, or stop blood flow, thereby aiding the hemostasis process.


The clips of the present invention may be delivered using various apparatus and methods. An exemplary apparatus 500 suitable for delivering a clip of the present invention is shown in FIG. 9. Other suitable apparatus that may be used to deliver a clip of the present invention are disclosed in co-pending U.S. application Ser. No. 10/081,723, filed on the same day as the present application and entitled “Apparatus and Methods for Delivering a Closure Device”, which is assigned to the assignee of the present application. The disclosures of this application and any references cited therein are expressly incorporated by reference.


Generally, the apparatus 500 includes an introducer sheath 552, and a housing or carrier assembly 554 slidably disposed on the sheath 552. The sheath 552 includes a substantially flexible or semi-rigid tubular body 558 including a lumen 560 extending between its proximal and distal ends 562, 564. The distal end 564 has a size and shape configured to facilitate insertion into a blood vessel, e.g., having a tapered tip for facilitating substantially atraumatic introduction through the passage and at least partially into the vessel. The lumen 560 has a size for inserting one or more devices therethrough, such as a catheter, guidewire, and the like (not shown). The sheath 552 also preferably includes one or more seals (not shown), such as a hemostatic valve, within the lumen 560 at or near the proximal end 562 that provides a fluid-tight seal, yet accommodates inserting one or more devices into the lumen 560 without fluid passing proximally from the sheath 552.


Optionally, the sheath 552 may include a side port 566 that communicates with the lumen 560, for example, to deliver fluids into the lumen 560. Alternatively, or in addition, the side port 566 may be used to provide a “bleed back” indicator. An exemplary “bleed back” indicator and related methods of use are disclosed in co-pending application Ser. No. 09/680,837, filed Oct. 6, 2000, entitled “Apparatus and Methods for Positioning a Vascular Sheath,” which is assigned to the assignee of the present application. The disclosure of this application and any other references cited therein are fully incorporated by reference herein.


The apparatus 500 may also include a mechanical locator or obturator 600, such as that disclosed in U.S. application Ser. No. 10/081,723, incorporated by referenced above, that may be part of an actuator assembly (not shown) that is attachable to the proximal end of the sheath 552. Alternatively, the mechanical locator or obturator 600 may be a separate device that is insertable into the lumen 560, e.g., through the actuator assembly. Generally, the obturator 600 is an elongate member including a distal tip 614 and a distal portion 616. The distal tip 614 may be substantially soft and/or flexible such that the distal tip 614 may substantially atraumatically enter the vessel 590 (not shown, see FIGS. 10A-10D). The distal portion 616 generally includes one or more wings or other expandable elements 618 for providing tactile feedback, as described further below.


The carrier assembly 554 is slidably disposed on an exterior of the sheath 552, and is configured for releasably carrying a clip 110 (shown in phantom), which may any of the clips described herein. The carrier assembly 554 may be substantially permanently attached to the sheath 552 and/or may be actuated from the proximal end 562 of the sheath 552, for example, by the actuator assembly (not shown), to advance the clip 110 distally during deployment. Alternatively, the clip 110 may be carried by an actuator assembly, as disclosed in co-pending U.S. application Ser. No. 10/081,725, filed on the same day as the present application and entitled “Sheath Apparatus and Methods for Delivering a Closure Device,” which is assigned to the assignee of the present application. The disclosures of this application and any references cited therein are expressly incorporated herein by reference.


Turning to FIGS. 10A-D, the apparatus 500 may be used to deliver the clip 110 to close and/or seal an incision, puncture, or other passage 592 that extends from a patient's skin 594, through intervening tissue 596, and into a wall 598 of a vessel 590 or other body lumen. Alternatively, the apparatus 500 may be used to deliver the clip 110 to engage tissue in other procedures, e.g., to connect tissue segments together or otherwise to secure tissue structures with respect to one another. For example, the apparatus 500 and clip 110 may be used to attach an anastomosis during a bypass procedure. It will be appreciated by those skilled in the art that the clip 110 and/or apparatus 500 may be useful in a variety of procedures.


As shown in FIG. 10A, the sheath 552 may be inserted or otherwise positioned within the vessel 590, i.e., through the passage 592. The sheath 552 may be advanced over a guidewire or other rail (not shown) previously positioned through the passage 592 into the vessel 590 or advanced in conjunction with a pointed stylet directly through tissue using conventional procedures. Preferably, the vessel 590 is a peripheral vessel, such as a femoral, radial, or carotid artery, although other body lumens may be accessed using the sheath 552, as will be appreciated by those skilled in the art.


The passage 592, and consequently the sheath 552, may be oriented at an angle “alpha” with respect to the vessel 590, thereby facilitating introducing devices through the lumen 560 of the sheath 552 into the vessel 590 with minimal risk of damage to the vessel 590. One or more devices, such as a guide wire, a catheter, and the like (not shown), may be inserted through the sheath 552 and advanced to a desired location within the patient's body. For example, the devices may be used to perform a therapeutic or diagnostic procedure, such as angioplasty, atherectomy, stent implantation, and the like, within the patient's vasculature.


After the procedure is complete, any devices used during the procedure may be removed from the sheath 552, and the obturator 600 may be inserted into the lumen 560. For example, the obturator 600 may be part of an actuator assembly (not shown), and may be advanced through the lumen when the actuator assembly is attached to the proximal end of the sheath 552. Alternatively, the actuator assembly and obturator 600 may be coupled separately to the sheath 552.


When the obturator 600 is fully inserted within the sheath 552, the distal portion 616 of the obturator 600 may extend beyond the distal end 564 of the sheath 552. In an alternative embodiment, the obturator 600 may be attached to an exterior surface (not shown) of the sheath 552, for example, along a track, e.g., including cooperating slots, grooves, and the like (not shown) in the sheath 552 and obturator 600.


Turning to FIG. 10B, the expandable elements 618 on the distal portion of the obturator 600 may then be directed to their expanded configuration, for example, by activating a switch on the proximal end (not shown) of the obturator 600. With the sheath 552 and obturator 600 coupled to one another, the sheath 552 and obturator 600 may be moved in conjunction with one another.


As shown in FIG. 10C, the sheath 552 may be partially withdrawn from the vessel 590, until the expandable elements 618 contact the wall 598 of the vessel 590. Thus, the expandable elements 618 may provide a tactile indication of the position of the sheath 552 with respect to the wall 598 of the vessel 590. In addition, the expandable elements 618 may assist in “presenting” the wall 598 of the vessel 590, e.g., for receiving the clip 110.


Generally, the clip 110 is carried by the carrier assembly 554 before the procedure. The clip 110 may be constrained in its transverse configuration on the carrier assembly 554, and the carrier assembly 554 may be provided on or adjacent the proximal end of the sheath 552. Because the tines, which may include primary and secondary tines 114, 116 may be biased towards one another, the tines 114, 116 may slidably contact an inner surface (not shown) of the carrier assembly 554 or an outer surface of the sheath 552, thereby constraining the clip 110 in its transverse configuration.


Turning to FIG. 10D, with the sheath 552 properly positioned, the carrier assembly 554 may then be actuated, for example, to advance the carrier assembly 554 distally over the sheath 552 to deliver the clip 110. Preferably, the carrier assembly 554 may only be advanced a predetermined fixed distance relative to the distal end of the sheath 552, and consequently, the expandable elements 618 of the obturator 600, such that the clip 110 substantially engages the wall 598 of the blood vessel 590. This predetermined distance may facilitate properly deploying the clip 110 with respect to the wall 598 of the vessel 590, e.g., to prevent advancing the clip 110 too far, i.e., into the vessel 590.


As the clip 110 is deployed from the carrier assembly 554, the clip 110 may be expanded to an enlarged diameter. For example, a distal end of the carrier assembly 554 may include a ramped region (not shown) that may deflect the tines 114, 116, and/or the body of the clip 110 radially outwardly. As the clip 110 is advanced over the ramped region, the tines 114, 116 may be deflected radially outwardly as they are being driven into the surrounding tissue, thereby engaging a larger region of tissue than if the tines 114, 116 had been maintained substantially axially.


Alternatively, the clip 110 may include expandable looped elements and/or spring elements (not shown), such as those described above, that may facilitate expanding the clip 110 as it is deployed from the carrier assembly 554 and/or the sheath 552. For example, the looped elements of the clip 110 may be compressed when the clip 110 is loaded into the carrier assembly 554, e.g., thereby allowing a relatively smaller profile carrier assembly 554 to be used. The clip 110 may automatically expand upon deployment from the carrier assembly 554 to engage a larger region of tissue surrounding the opening, such as an arteriotomy 591 in the wall 598 of the vessel 590 (see FIG. 11A).


Once the clip 110 is deployed entirely or otherwise released from the sheath 552, the clip 110 may resiliently move towards its substantially planar configuration, such as that shown in FIG. 11B.


During delivery of the clip 110, radiopaque markers (not shown) on the clip 110, the carrier assembly 554, and/or the expandable members 618 may be monitored, e.g., using fluoroscopy, to facilitate observing and/or positioning the apparatus 500. Thus, a relative position of the clip 110 with respect to the expandable elements 618, and consequently to the wall 598 of the vessel 590, may be ascertained before the clip 110 is deployed from the carrier assembly 554.


Turning to FIGS. 11A and 11B, in a preferred embodiment, the expandable elements 618 of the obturator 600 may be rotationally offset from the one or more tines 114 on the clip 110. For example, if the clip 110 includes primary tines (such as those shown in FIGS. 2A and 3), the obturator 600 and clip 110 may have a predetermined relative angular orientation about the central axis 124. Preferably, the clip 110 is loaded onto the carrier assembly 554 in a predetermined angular orientation and the obturator 600 is receivable in the sheath 552 only in a predetermined angular orientation that is offset such that the tines 114, 116 are out of axial alignment with the expandable elements 618, as shown in FIG. 11A.


This predetermined rotational orientation may substantially minimize the possibility of the primary tines 114 contacting and/or damaging the expandable elements 618. For example, with particular reference to FIG. 11A, a preferred relative angular orientation of the clip 100 and obturator 600 is shown relative to an arteriotomy 591 in the wall 598 of the vessel 590. Here, the expandable elements 618 are oriented to crisscross diagonally the arteriotomy 591 within the interior of the vessel 590. Generally, because of the natural structure of the tissue in the wall of a vessel, an arteriotomy generally tends to adopt an elongate shape that extends transversely to the direction of flow (i.e., across the circumference of the vessel wall).


The primary tines 114 are oriented such that the primary tines 114 pierce the wall 598 of the vessel 590 on either side of the arteriotomy 591, as shown. With the expandable elements 618 crisscrossing diagonally, risk of contact with the primary tines 114 is substantially reduced. Thus, the primary tines 114 may be sufficiently long to extend entirely through the wall 598 of the vessel 590 while avoiding the expandable elements 618.


The expandable elements 618 may then be collapsed and/or withdrawn into the distal end 564 of the sheath 552. As the clip 110 is released entirely from the sheath 552, the primary tines 114 may partially overlap, as shown in FIG. 11B, thereby pulling the arteriotomy 591 closed, similar to a single-thread suture. For example, the expandable elements 618 may be automatically collapsed immediately before or after the clip 110 is deployed from the carrier assembly 554 or when the carrier assembly 554 reaches its extreme distal position. Preferably, the distal portion 616 of the obturator 600 is collapsed and retracted into the sheath 554 after the primary tines 114 have pierced the wall 598 of the vessel 590, but before the clip 110 is entirely released from the sheath 552.


In addition, if the clip 110 includes secondary tines 116 (such as those shown in FIG. 2A), the secondary tines 116 may partially penetrate the wall 598 of the vessel 590 during deployment of the clip 110. Preferably, the lengths of the secondary tines 116 are relatively short or stop members (not shown) may be provided that prevent the secondary tines 116 from piercing entirely through the wall 598. When the clip 110 is released, the secondary tines 116 may pull the tissue inwardly, behaving somewhat similarly to a purse-string suture, to enhance closing the arteriotomy 591.


Once the clip 110 is successfully deployed into the wall 598 of the vessel 590, e.g., on either side of an arteriotomy 591, the apparatus 500 may be withdrawn from the passage 592. The entire apparatus 500 may be removed in one step, or alternatively, the obturator 600 may first be withdrawn from the sheath 552 before withdrawing the sheath 552, thereby leaving the clip 110 in place to close the arteriotomy 591 and/or seal the passage 592. In addition, if desired, a sealant or other material may be introduced into the passage 592 in conjunction with or separate from delivery of the clip 110 to further seal the passage 592, as is known to those skilled in the art.


While the invention is susceptible to various modifications, and alternative forms, specific examples thereof have been shown in the drawings and are herein described in detail. It should be understood, however, that the invention is not to be limited to the particular forms or methods disclosed, but to the contrary, the invention is to cover all modifications, equivalents and alternatives falling within the spirit and scope of the appended claims.

Claims
  • 1. A vessel closure device, comprising: an annular body defining a plane and disposed about a central axis at the center of an opening of the body, the body being movable between a generally planar, deployed configuration lying generally in the plane and a generally cylindrical, pre-deployment configuration extending out of the plane of the body, wherein the body is spring biased to move to the generally planar, deployed configuration from the generally cylindrical, pre-deployment configuration, the body having a serpentine orientation with a plurality of looped elements comprising alternating first and second curved regions, the first curved regions defining an inner periphery of the body and having an apex and the second curved regions defining an outer periphery of the body in the planar configuration; anda plurality of tissue attachment features extending from the first curved regions, the attachment features extending from the apex of the respective first curved region and being oriented generally into the opening of the body in the planar, deployed configuration towards the central axis in a manner that does not interfere with insertion and removal of a procedural sheath through the opening, and generally parallel to the central axis in the generally cylindrical, pre-deployment configuration.
  • 2. A device as in claim 1, wherein the attachment features comprise tines.
  • 3. A device as in claim 1, wherein each of the attachment features extends along an axis that is offset from the central axis when the device is in the planar configuration.
  • 4. A device as in claim 1, wherein each of the attachment features extends along an axis that is angled away from central axis when the device is in the planar configuration.
  • 5. A device as in claim 1, wherein the annular body has a spring force that closes the annular body from the cylindrical configuration to the planar configuration pursuant to a generally linear rather than radial bias.
  • 6. A vessel closure device, comprising: an annular body defining a plane and disposed about a central axis at the center of an opening of the body, the body having a serpentine orientation and being movable between an expanded cylindrical, pre-deployment configuration extending out of the plane of the body and a generally planar compressed, deployed configuration, wherein the body is spring biased to move to the generally planar compressed, deployed configuration from the expanded cylindrical, pre-deployment configuration, and wherein the body applies a generally linear force to tissue as the body moves toward the planar compressed configuration; anda plurality of tissue attachment features having a distal end, each of the plurality of tissue attachment features extending in a direction away from the body, for attaching to tissue, each tissue attachment feature having a longitudinal axis, wherein when the body is in the compressed configuration the distal end of each of the plurality of tissue attachment features is remote from the body, wherein a portion of the body adjacent the longitudinal axis, and extending from an inner periphery of the body towards an outer periphery of the body, extends towards the longitudinal axis in the compressed configuration and extends away from the longitudinal axis in the expanded configuration, such that the tissue engagement features engage the vessel in the generally planar, deployed configuration.
  • 7. A device as in claim 6, wherein the attachment features are oriented generally into the opening of the body in the planar compressed configuration in a manner that does not interfere with insertion and removal of a procedural sheath through the opening, and generally parallel to the central axis in the expanded configuration.
  • 8. A device as in claim 6, wherein the attachment features are tines.
  • 9. A vessel closure device, comprising: an annular body defining a plane and disposed about a central axis at the center of an opening of the body, the body being movable between a generally planar, deployed configuration lying generally in the plane and a generally cylindrical, pre-deployment configuration extending out of the plane of the body, wherein the body is spring biased to move to the generally planar, deployed configuration from the generally cylindrical, pre-deployment configuration, the body having a serpentine orientation with a plurality of looped elements comprising alternating first and second curved regions, the first curved regions defining an inner periphery of the body and having an apex and the second curved regions defining an outer periphery of the body in the planar configuration; anda plurality of tines extending from the first curved regions, the tines extending from the apex of the respective first curved region and being oriented generally into the opening of the body in the planar, deployed configuration towards the central axis, and generally parallel to the central axis in the generally cylindrical, pre-deployment configuration.
  • 10. A device as in claim 9, wherein each of the tines extends along an axis that is offset from the central axis when the device is in the planar configuration.
  • 11. A device as in claim 9, wherein each of the tines extends along an axis that is angled away from central axis when the device is in the planar configuration.
  • 12. A device as in claim 9, wherein the annular body has a spring force that closes the annular body from the cylindrical configuration to the planar configuration pursuant to a generally linear rather than radial bias.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 10/667,144, filed Sep. 19, 2003, now U.S. Pat. No. 8,128,644, which is a continuation of U.S. application Ser. No. 10/081,726, filed Feb. 21, 2002, now U.S. Pat. No. 6,623,510, which application is a continuation-in-part of U.S. application Ser. No. 09/732,178, filed Dec. 7, 2000, now U.S. Pat. No. 6,719,777, for “Closure Device and Methods for Making and Using Them,” the disclosures of which are expressly incorporated by reference herein.

US Referenced Citations (1023)
Number Name Date Kind
287046 Norton Oct 1883 A
438400 Brennen Oct 1890 A
556082 Boeddinghaus Mar 1896 A
1088393 Backus Feb 1914 A
1123290 Von Herff Jan 1915 A
1242139 Callahan Oct 1917 A
1331401 Summers Feb 1920 A
1480935 Gleason Jan 1924 A
1596004 De Bengoa Aug 1926 A
1647958 Ciarlante Nov 1927 A
1880569 Weis Oct 1932 A
2087074 Tucker Jul 1937 A
2210061 Caminez Aug 1940 A
2254620 Miller Sep 1941 A
2316297 Southerland et al. Apr 1943 A
2371978 Perham Mar 1945 A
2453227 James Nov 1948 A
2583625 Bergan Jan 1952 A
2684070 Kelsey Jul 1954 A
2755699 Forster Jul 1956 A
2910067 White Oct 1959 A
2944311 Schneckenberger Jul 1960 A
2951482 Sullivan Sep 1960 A
2969887 Darmstadt et al. Jan 1961 A
3015403 Fuller Jan 1962 A
3113379 Frank Dec 1963 A
3120230 Skold Feb 1964 A
3142878 Santora Aug 1964 A
3209754 Brown Oct 1965 A
3348595 Stevens, Jr. Oct 1967 A
3357070 Sloan Dec 1967 A
3482428 Kapitanov et al. Dec 1969 A
3494533 Green et al. Feb 1970 A
3510923 Blake May 1970 A
3523351 Filia Aug 1970 A
3586002 Wood et al. Jun 1971 A
3604425 Le Roy Sep 1971 A
3618447 Goins Nov 1971 A
3677243 Nerz Jul 1972 A
3682180 McFarlane Aug 1972 A
3757629 Schneider Sep 1973 A
3805337 Branstetter Apr 1974 A
3823719 Cummings Jul 1974 A
3828791 Santos Aug 1974 A
3856016 Davis Dec 1974 A
3874388 King et al. Apr 1975 A
3908662 Razgulov et al. Sep 1975 A
3926194 Greenberg et al. Dec 1975 A
3939820 Grayzel Feb 1976 A
3944114 Coppens Mar 1976 A
3960147 Murray Jun 1976 A
3985138 Jarvik Oct 1976 A
4007743 Blake Feb 1977 A
4014492 Rothfuss Mar 1977 A
4018228 Goosen Apr 1977 A
4047533 Perciaccante et al. Sep 1977 A
4064881 Meredith Dec 1977 A
4112944 Williams Sep 1978 A
4153321 Pombrol May 1979 A
4162673 Patel Jul 1979 A
4169476 Hiltebrandt Oct 1979 A
4189808 Brown Feb 1980 A
4192315 Hilzinger et al. Mar 1980 A
4201215 Crossett et al. May 1980 A
4204541 Kapitanov May 1980 A
4207870 Eldridge Jun 1980 A
4214587 Sakura, Jr. Jul 1980 A
4215699 Patel Aug 1980 A
4217902 March Aug 1980 A
4267995 McMillan May 1981 A
4273129 Boebel Jun 1981 A
4274415 Kanamoto et al. Jun 1981 A
4278091 Borzone Jul 1981 A
4317445 Robinson Mar 1982 A
4317451 Cerwin et al. Mar 1982 A
4318401 Zimmerman Mar 1982 A
4327485 Rix May 1982 A
4345606 Littleford Aug 1982 A
4368736 Kaster Jan 1983 A
4396139 Hall et al. Aug 1983 A
4407286 Noiles et al. Oct 1983 A
4411654 Boarini et al. Oct 1983 A
4412832 Kling et al. Nov 1983 A
4428376 Mericle Jan 1984 A
4440170 Golden et al. Apr 1984 A
4449531 Cerwin et al. May 1984 A
4475544 Reis Oct 1984 A
4480356 Martin Nov 1984 A
4485816 Krumme Dec 1984 A
RE31855 Osborne Mar 1985 E
4505273 Braun et al. Mar 1985 A
4505274 Speelman Mar 1985 A
4523591 Kaplan et al. Jun 1985 A
4523695 Braun et al. Jun 1985 A
4525157 Vaillancourt Jun 1985 A
4526174 Froehlich Jul 1985 A
4570633 Golden Feb 1986 A
4586503 Kirsch et al. May 1986 A
4592498 Braun et al. Jun 1986 A
4596559 Fleischhacker Jun 1986 A
4607638 Crainich Aug 1986 A
4610251 Kumar Sep 1986 A
4610252 Catalano Sep 1986 A
4635634 Santos Jan 1987 A
4644956 Morgenstern Feb 1987 A
4651737 Deniega Mar 1987 A
4664305 Blake, III et al. May 1987 A
4665906 Jervis May 1987 A
4687469 Osypka Aug 1987 A
4693249 Schenck et al. Sep 1987 A
4697312 Freyer Oct 1987 A
4719917 Barrows et al. Jan 1988 A
4724840 McVay et al. Feb 1988 A
4738658 Magro et al. Apr 1988 A
4744364 Kensey May 1988 A
4747407 Liu et al. May 1988 A
4759364 Boebel Jul 1988 A
4771782 Millar Sep 1988 A
4772266 Groshong Sep 1988 A
4777950 Kees, Jr. Oct 1988 A
4789090 Blake, III Dec 1988 A
4832688 Sagae et al. May 1989 A
4836204 Landymore et al. Jun 1989 A
4852568 Kensey Aug 1989 A
4860746 Yoon Aug 1989 A
4865026 Barrett Sep 1989 A
4874122 Froelich et al. Oct 1989 A
4878915 Brantigan Nov 1989 A
4885003 Hillstead Dec 1989 A
4886067 Palermo Dec 1989 A
4887601 Richards Dec 1989 A
4890612 Kensey Jan 1990 A
4902508 Badylak et al. Feb 1990 A
4917087 Walsh et al. Apr 1990 A
4917089 Sideris Apr 1990 A
4929240 Kirsch et al. May 1990 A
4934364 Green Jun 1990 A
4950258 Kawai et al. Aug 1990 A
4957499 Lipatov et al. Sep 1990 A
4961729 Vaillancourt Oct 1990 A
4967949 Sandhaus Nov 1990 A
4976721 Blasnik et al. Dec 1990 A
4983176 Cushman et al. Jan 1991 A
4997436 Oberlander Mar 1991 A
4997439 Chen Mar 1991 A
5002562 Oberlander Mar 1991 A
5007921 Brown Apr 1991 A
5011487 Shichman Apr 1991 A
5015247 Michelson May 1991 A
5021059 Kensey et al. Jun 1991 A
5026390 Brown Jun 1991 A
5030226 Green et al. Jul 1991 A
5032127 Frazee et al. Jul 1991 A
5035692 Lyon et al. Jul 1991 A
5042707 Taheri Aug 1991 A
5047047 Yoon Sep 1991 A
5053008 Bajaj Oct 1991 A
5059201 Asnis Oct 1991 A
5061274 Kensey Oct 1991 A
5061283 Silvestrini Oct 1991 A
5078731 Hayhurst Jan 1992 A
5092941 Miura Mar 1992 A
5100418 Yoon et al. Mar 1992 A
5100422 Berguer et al. Mar 1992 A
5108420 Marks Apr 1992 A
5108421 Fowler Apr 1992 A
5114032 Laidlaw May 1992 A
5114065 Storace May 1992 A
5116349 Aranyi May 1992 A
5122122 Allgood Jun 1992 A
5122156 Granger et al. Jun 1992 A
5131379 Sewell, Jr. Jul 1992 A
5141520 Goble et al. Aug 1992 A
5147381 Heimerl et al. Sep 1992 A
5156609 Nakao et al. Oct 1992 A
5163343 Gish Nov 1992 A
5167634 Corrigan, Jr. et al. Dec 1992 A
5167643 Lynn Dec 1992 A
5171249 Stefanchik et al. Dec 1992 A
5171250 Yoon Dec 1992 A
5171259 Inoue Dec 1992 A
5176648 Holmes et al. Jan 1993 A
5192288 Thompson et al. Mar 1993 A
5192300 Fowler Mar 1993 A
5192301 Kamiya et al. Mar 1993 A
5192302 Kensey et al. Mar 1993 A
5192602 Spencer et al. Mar 1993 A
5193533 Body et al. Mar 1993 A
5197971 Bonutti Mar 1993 A
5209756 Seedhom et al. May 1993 A
5217024 Dorsey et al. Jun 1993 A
5222974 Kensey et al. Jun 1993 A
5226908 Yoon Jul 1993 A
5236435 Sewell, Jr. Aug 1993 A
5242456 Nash et al. Sep 1993 A
5242457 Akopov et al. Sep 1993 A
5242459 Buelna Sep 1993 A
5243857 Velez Sep 1993 A
5246156 Rothfuss et al. Sep 1993 A
5246443 Mai Sep 1993 A
5250058 Miller et al. Oct 1993 A
5254105 Haaga Oct 1993 A
5255679 Imran Oct 1993 A
5269792 Kovac et al. Dec 1993 A
5275616 Fowler Jan 1994 A
5281422 Badylak et al. Jan 1994 A
5282808 Kovac et al. Feb 1994 A
5282827 Kensey et al. Feb 1994 A
5284488 Sideris Feb 1994 A
5289963 McGarry et al. Mar 1994 A
5290243 Chodorow et al. Mar 1994 A
5290310 Makower et al. Mar 1994 A
5292309 Van Tassel et al. Mar 1994 A
5292332 Lee Mar 1994 A
5304183 Gourlay et al. Apr 1994 A
5304184 Hathaway et al. Apr 1994 A
5304204 Bregen Apr 1994 A
5306254 Nash et al. Apr 1994 A
5309927 Welch May 1994 A
5318542 Hirsch et al. Jun 1994 A
5320639 Rudnick Jun 1994 A
5322694 Sixsmith Jun 1994 A
5327908 Gerry Jul 1994 A
5330445 Haaga Jul 1994 A
5330503 Yoon Jul 1994 A
5334216 Vidal et al. Aug 1994 A
5334217 Das Aug 1994 A
5335680 Moore Aug 1994 A
5340360 Stefanchik Aug 1994 A
5342393 Stack Aug 1994 A
5344439 Otten Sep 1994 A
5350399 Erlebacher et al. Sep 1994 A
5352229 Goble et al. Oct 1994 A
5354279 Hofling Oct 1994 A
5364406 Sewell, Jr. Nov 1994 A
5364408 Gordon Nov 1994 A
5366458 Korthoff et al. Nov 1994 A
5366479 McGarry et al. Nov 1994 A
5383896 Gershony et al. Jan 1995 A
5383897 Wholey Jan 1995 A
RE34866 Kensey et al. Feb 1995 E
5392978 Valez et al. Feb 1995 A
5395030 Kuramoto et al. Mar 1995 A
5404621 Heinke Apr 1995 A
5411520 Nash et al. May 1995 A
5413571 Katsaros et al. May 1995 A
5413584 Schulze May 1995 A
5416584 Kay May 1995 A
5417699 Klein et al. May 1995 A
5419765 Weldon et al. May 1995 A
5419777 Hofling May 1995 A
5421832 Lefebvre Jun 1995 A
5423857 Rosenman et al. Jun 1995 A
5425489 Shichman et al. Jun 1995 A
5425740 Hutchinson, Jr. Jun 1995 A
5431639 Shaw Jul 1995 A
5431667 Thompson et al. Jul 1995 A
5433721 Hooven et al. Jul 1995 A
5437631 Janzen Aug 1995 A
5439479 Shichman et al. Aug 1995 A
5443477 Marin et al. Aug 1995 A
5443481 Lee Aug 1995 A
5445167 Yoon et al. Aug 1995 A
5449359 Groiso Sep 1995 A
5451235 Lock et al. Sep 1995 A
5454413 Morelli Oct 1995 A
5456400 Shichman et al. Oct 1995 A
5462561 Voda Oct 1995 A
5464413 Siska, Jr. et al. Nov 1995 A
5466241 Leroy et al. Nov 1995 A
5470010 Rothfuss et al. Nov 1995 A
5471982 Edwards et al. Dec 1995 A
5474557 Mai Dec 1995 A
5474569 Zinreich et al. Dec 1995 A
5476505 Limon Dec 1995 A
5478352 Fowler Dec 1995 A
5478353 Yoon Dec 1995 A
5478354 Tovey et al. Dec 1995 A
5484420 Russo Jan 1996 A
5486195 Myers et al. Jan 1996 A
5496332 Sierra et al. Mar 1996 A
5497933 DeFonzo et al. Mar 1996 A
5507744 Tay et al. Apr 1996 A
5507755 Gresl et al. Apr 1996 A
5510115 Breillatt, Jr. et al. Apr 1996 A
5522840 Krajicek Jun 1996 A
5527322 Klein et al. Jun 1996 A
5536251 Evard et al. Jul 1996 A
5540712 Kleshinski et al. Jul 1996 A
5540716 Hlavacek Jul 1996 A
5544802 Crainich Aug 1996 A
5545178 Kensey et al. Aug 1996 A
5547474 Kloeckl et al. Aug 1996 A
5560532 DeFonzo et al. Oct 1996 A
5571120 Yoon Nov 1996 A
5573784 Badylak et al. Nov 1996 A
5575771 Walinsky Nov 1996 A
5582616 Bolduc et al. Dec 1996 A
5584879 Reimold et al. Dec 1996 A
5591205 Fowler Jan 1997 A
5593412 Martinez et al. Jan 1997 A
5601602 Fowler Feb 1997 A
5609597 Lehrer Mar 1997 A
5613974 Andreas et al. Mar 1997 A
5618291 Thompson et al. Apr 1997 A
5620452 Yoon Apr 1997 A
5620461 Muijs et al. Apr 1997 A
5626614 Hart May 1997 A
5634936 Lindon et al. Jun 1997 A
5643318 Tsukernik et al. Jul 1997 A
5645565 Rudd et al. Jul 1997 A
5645566 Brenneman et al. Jul 1997 A
5645567 Crainich Jul 1997 A
5649959 Hannam et al. Jul 1997 A
D383539 Croley Sep 1997 S
5669935 Rosenman et al. Sep 1997 A
5674231 Green et al. Oct 1997 A
5676689 Kensey et al. Oct 1997 A
5676974 Valdes et al. Oct 1997 A
5681280 Rusk et al. Oct 1997 A
5681334 Evans et al. Oct 1997 A
5683405 Yacoubian et al. Nov 1997 A
5690674 Diaz Nov 1997 A
5695504 Gifford, III et al. Dec 1997 A
5695505 Yoon Dec 1997 A
5695524 Kelley et al. Dec 1997 A
5697943 Sauer et al. Dec 1997 A
5700273 Buelna et al. Dec 1997 A
5709224 Behl et al. Jan 1998 A
5715987 Kelley et al. Feb 1998 A
5716375 Fowler Feb 1998 A
5720755 Dakov Feb 1998 A
5725498 Janzen et al. Mar 1998 A
5725552 Kotula et al. Mar 1998 A
5725554 Simon et al. Mar 1998 A
5728110 Vidal et al. Mar 1998 A
5728114 Evans et al. Mar 1998 A
5728116 Rosenman Mar 1998 A
5728122 Leschinsky et al. Mar 1998 A
5728132 Van Tassel et al. Mar 1998 A
5728133 Kontos Mar 1998 A
5732872 Bolduc et al. Mar 1998 A
5735736 Volk Apr 1998 A
5735873 MacLean Apr 1998 A
5749826 Faulkner May 1998 A
5752966 Chang May 1998 A
5755726 Pratt et al. May 1998 A
5755727 Kontos May 1998 A
5755778 Kleshinski May 1998 A
5766217 Christy Jun 1998 A
5766246 Mulhauser et al. Jun 1998 A
5769870 Salahieh et al. Jun 1998 A
5776147 Dolendo Jul 1998 A
5779707 Bertholet et al. Jul 1998 A
5780807 Saunders Jul 1998 A
5782844 Yoon et al. Jul 1998 A
5782860 Epstein et al. Jul 1998 A
5782861 Cragg et al. Jul 1998 A
5795958 Rao et al. Aug 1998 A
5797928 Kogasaka Aug 1998 A
5797931 Bito et al. Aug 1998 A
5797933 Snow et al. Aug 1998 A
5797958 Yoon Aug 1998 A
5797960 Stevens et al. Aug 1998 A
5810776 Bacich et al. Sep 1998 A
5810846 Virnich et al. Sep 1998 A
5810851 Yoon Sep 1998 A
5817113 Gifford, III et al. Oct 1998 A
5820631 Nobles Oct 1998 A
5827298 Hart et al. Oct 1998 A
5830125 Scribner et al. Nov 1998 A
5830217 Ryan Nov 1998 A
5830221 Stein et al. Nov 1998 A
5833698 Hinchliffe et al. Nov 1998 A
5843164 Frantzen et al. Dec 1998 A
5843167 Dwyer et al. Dec 1998 A
5845657 Carberry et al. Dec 1998 A
5853421 Leschinsky et al. Dec 1998 A
5853422 Huebsch et al. Dec 1998 A
5855312 Toledano Jan 1999 A
5858082 Cruz et al. Jan 1999 A
5860991 Klein et al. Jan 1999 A
5861003 Latson et al. Jan 1999 A
5861005 Kontos Jan 1999 A
5868755 Kanner et al. Feb 1999 A
5868762 Cragg et al. Feb 1999 A
5868763 Spence et al. Feb 1999 A
5871474 Hermann et al. Feb 1999 A
5871501 Leschinsky et al. Feb 1999 A
5871525 Edwards et al. Feb 1999 A
5873876 Christy Feb 1999 A
5873891 Sohn Feb 1999 A
5879366 Shaw et al. Mar 1999 A
5891088 Thompson et al. Apr 1999 A
5897487 Ouchi Apr 1999 A
5902310 Foerster et al. May 1999 A
5904697 Gifford, III et al. May 1999 A
5904703 Gilson May 1999 A
5906631 Imran May 1999 A
5907893 Zadno-Azizi et al. Jun 1999 A
5908149 Welch et al. Jun 1999 A
5910155 Ratcliff et al. Jun 1999 A
5919207 Taheri Jul 1999 A
5922009 Epstein et al. Jul 1999 A
5928231 Klein et al. Jul 1999 A
5928251 Aranyi et al. Jul 1999 A
5928260 Chin et al. Jul 1999 A
5935147 Kensey et al. Aug 1999 A
5938667 Peyser et al. Aug 1999 A
5941890 Voegele et al. Aug 1999 A
5947999 Groiso Sep 1999 A
5948001 Larsen Sep 1999 A
5951518 Licata et al. Sep 1999 A
5951575 Bolduc et al. Sep 1999 A
5951576 Wakabayashi Sep 1999 A
5951589 Epstein et al. Sep 1999 A
5954732 Hart et al. Sep 1999 A
5957900 Ouchi Sep 1999 A
5957936 Yoon et al. Sep 1999 A
5957938 Zhu et al. Sep 1999 A
5957940 Tanner et al. Sep 1999 A
5964782 Lafontaine et al. Oct 1999 A
5972023 Tanner et al. Oct 1999 A
5976161 Kirsch et al. Nov 1999 A
5976174 Ruiz Nov 1999 A
5984934 Ashby et al. Nov 1999 A
5984948 Hasson Nov 1999 A
5984949 Levin Nov 1999 A
5993468 Rygaard Nov 1999 A
5993476 Groiso Nov 1999 A
6001110 Adams Dec 1999 A
6004341 Zhu et al. Dec 1999 A
6007563 Nash et al. Dec 1999 A
6010517 Baccaro Jan 2000 A
6013084 Ken et al. Jan 2000 A
6015815 Mollison Jan 2000 A
6019779 Thorud et al. Feb 2000 A
6022372 Kontos Feb 2000 A
6024750 Mastri Feb 2000 A
6024756 Huebsch et al. Feb 2000 A
6030364 Durgin et al. Feb 2000 A
6030413 Lazarus Feb 2000 A
6033427 Lee Mar 2000 A
6036703 Evans et al. Mar 2000 A
6036720 Abrams et al. Mar 2000 A
6045570 Epstein et al. Apr 2000 A
6048358 Barak Apr 2000 A
6056768 Cates et al. May 2000 A
6056769 Epstein et al. May 2000 A
6056770 Epstein et al. May 2000 A
6059800 Hart et al. May 2000 A
6059825 Hobbs et al. May 2000 A
6063085 Tay et al. May 2000 A
6063114 Nash et al. May 2000 A
6071300 Brenneman et al. Jun 2000 A
6074395 Trott et al. Jun 2000 A
6077281 Das Jun 2000 A
6077291 Das Jun 2000 A
6080182 Shaw et al. Jun 2000 A
6080183 Tsugita et al. Jun 2000 A
6090130 Nash et al. Jul 2000 A
6095155 Criscuolo Aug 2000 A
6102271 Longo et al. Aug 2000 A
6110184 Weadock Aug 2000 A
6113610 Poncet Sep 2000 A
6113612 Swanson et al. Sep 2000 A
6117125 Rothbarth et al. Sep 2000 A
6117144 Nobles et al. Sep 2000 A
6117148 Ravo et al. Sep 2000 A
6117157 Tekulve Sep 2000 A
6117159 Huebsch et al. Sep 2000 A
6120524 Taheri Sep 2000 A
6126675 Shchervinsky et al. Oct 2000 A
6136010 Modesitt et al. Oct 2000 A
6146385 Torrie et al. Nov 2000 A
6149660 Laufer et al. Nov 2000 A
6149667 Hovland et al. Nov 2000 A
6152144 Lesh et al. Nov 2000 A
6152936 Christy et al. Nov 2000 A
6152937 Peterson et al. Nov 2000 A
6161263 Anderson Dec 2000 A
6165204 Levinson et al. Dec 2000 A
6171277 Ponzi Jan 2001 B1
6171329 Shaw et al. Jan 2001 B1
6174322 Schneidt Jan 2001 B1
6179849 Yencho et al. Jan 2001 B1
6179860 Fulton, III et al. Jan 2001 B1
6183775 Ventouras Feb 2001 B1
6193708 Ken et al. Feb 2001 B1
6193734 Bolduc et al. Feb 2001 B1
6197042 Ginn et al. Mar 2001 B1
6198974 Webster, Jr. Mar 2001 B1
6200329 Fung et al. Mar 2001 B1
6200330 Benderev et al. Mar 2001 B1
6206895 Levinson Mar 2001 B1
6206913 Yencho et al. Mar 2001 B1
6206931 Cook et al. Mar 2001 B1
6210407 Webster Apr 2001 B1
6210418 Storz et al. Apr 2001 B1
6217554 Green Apr 2001 B1
6220248 Voegele et al. Apr 2001 B1
6221102 Baker et al. Apr 2001 B1
6231561 Frazier et al. May 2001 B1
6238705 Liu et al. May 2001 B1
6241740 Davis et al. Jun 2001 B1
6245079 Nobles et al. Jun 2001 B1
6248124 Pedros et al. Jun 2001 B1
6254617 Spence et al. Jul 2001 B1
6254642 Taylor Jul 2001 B1
6258115 Dubrul Jul 2001 B1
6267773 Gadberry et al. Jul 2001 B1
6273903 Wilk Aug 2001 B1
6277140 Ginn et al. Aug 2001 B2
6280460 Bolduc et al. Aug 2001 B1
6287322 Zhu et al. Sep 2001 B1
6287335 Drasler et al. Sep 2001 B1
6290674 Roue et al. Sep 2001 B1
6296657 Brucker Oct 2001 B1
6302870 Jacobsen et al. Oct 2001 B1
6302898 Edwards et al. Oct 2001 B1
6305891 Burlingame Oct 2001 B1
6309416 Swanson et al. Oct 2001 B1
6319258 McAllen, III et al. Nov 2001 B1
6322580 Kanner Nov 2001 B1
6328727 Frazier et al. Dec 2001 B1
6329386 Mollison Dec 2001 B1
6334865 Redmond et al. Jan 2002 B1
6348064 Kanner Feb 2002 B1
6355052 Neuss et al. Mar 2002 B1
6358258 Arcia et al. Mar 2002 B1
6375671 Kobayashi et al. Apr 2002 B1
D457958 Dycus May 2002 S
6383208 Sancoff et al. May 2002 B1
6391048 Ginn et al. May 2002 B1
6395015 Borst et al. May 2002 B1
6398752 Sweezer et al. Jun 2002 B1
6402765 Monassevitch et al. Jun 2002 B1
6409739 Nobles et al. Jun 2002 B1
6419669 Frazier et al. Jul 2002 B1
6421899 Zitnay Jul 2002 B1
6423054 Ouchi Jul 2002 B1
6425911 Akerfeldt et al. Jul 2002 B1
6428472 Haas Aug 2002 B1
6428548 Durgin et al. Aug 2002 B1
6443158 Lafontaine et al. Sep 2002 B1
6443963 Baldwin et al. Sep 2002 B1
6447540 Fontaine et al. Sep 2002 B1
6450391 Kayan et al. Sep 2002 B1
6455053 Okada et al. Sep 2002 B1
6458130 Frazier et al. Oct 2002 B1
6461364 Ginn et al. Oct 2002 B1
6482224 Michler et al. Nov 2002 B1
6488692 Spence et al. Dec 2002 B1
6500115 Krattiger et al. Dec 2002 B2
6506210 Kanner Jan 2003 B1
6508828 Akerfeldt et al. Jan 2003 B1
6514280 Gilson Feb 2003 B1
6517555 Caro Feb 2003 B1
6517569 Mikus et al. Feb 2003 B2
6527737 Kaneshige Mar 2003 B2
6533762 Kanner et al. Mar 2003 B2
6533812 Swanson et al. Mar 2003 B2
6537288 Vargas et al. Mar 2003 B2
6544230 Flaherty et al. Apr 2003 B1
6547806 Ding Apr 2003 B1
6551319 Lieberman Apr 2003 B2
6558349 Kirkman May 2003 B1
6569173 Blatter et al. May 2003 B1
6569185 Ungs May 2003 B2
6572629 Kalloo et al. Jun 2003 B2
6578585 Stachowski et al. Jun 2003 B1
6582452 Coleman et al. Jun 2003 B2
6582482 Gillman et al. Jun 2003 B2
6596012 Akerfeldt et al. Jul 2003 B2
6596013 Yang et al. Jul 2003 B2
6599303 Peterson et al. Jul 2003 B1
6599311 Biggs et al. Jul 2003 B1
6602263 Swanson et al. Aug 2003 B1
6610072 Christy et al. Aug 2003 B1
6613059 Schaller et al. Sep 2003 B2
6613060 Adams et al. Sep 2003 B2
6616686 Coleman et al. Sep 2003 B2
6620165 Wellisz Sep 2003 B2
6623509 Ginn Sep 2003 B2
6623510 Carley et al. Sep 2003 B2
6626918 Ginn et al. Sep 2003 B1
6626919 Swanstrom Sep 2003 B1
6626920 Whayne Sep 2003 B2
6626930 Allen et al. Sep 2003 B1
6632197 Lyon Oct 2003 B2
6632238 Ginn et al. Oct 2003 B2
6634537 Chen Oct 2003 B2
6645205 Ginn Nov 2003 B2
6645225 Atkinson Nov 2003 B1
6652538 Kayan et al. Nov 2003 B2
6652556 VanTassel et al. Nov 2003 B1
6663633 Pierson, III Dec 2003 B1
6663655 Ginn et al. Dec 2003 B2
6669714 Coleman et al. Dec 2003 B2
6673083 Kayan et al. Jan 2004 B1
6676665 Foley et al. Jan 2004 B2
6676671 Robertson et al. Jan 2004 B2
6676685 Pedros et al. Jan 2004 B2
6679904 Gleeson et al. Jan 2004 B2
6685707 Roman et al. Feb 2004 B2
6689147 Koster, Jr. Feb 2004 B1
6695867 Ginn et al. Feb 2004 B2
6699256 Logan et al. Mar 2004 B1
6702826 Liddicoat et al. Mar 2004 B2
6712836 Berg et al. Mar 2004 B1
6712837 Akerfeldt et al. Mar 2004 B2
6719777 Ginn et al. Apr 2004 B2
6726704 Loshakove et al. Apr 2004 B1
6736822 McClellan et al. May 2004 B2
6743195 Zucker Jun 2004 B2
6743243 Roy et al. Jun 2004 B1
6743259 Ginn Jun 2004 B2
6746472 Frazier et al. Jun 2004 B2
6749621 Pantages et al. Jun 2004 B2
6749622 McGuckin et al. Jun 2004 B2
6752813 Goldfarb et al. Jun 2004 B2
6755842 Kanner et al. Jun 2004 B2
6758855 Fulton, III et al. Jul 2004 B2
6767356 Kanner et al. Jul 2004 B2
6776784 Ginn Aug 2004 B2
6780197 Roe et al. Aug 2004 B2
6786915 Akerfeldt et al. Sep 2004 B2
6790218 Jayaraman Sep 2004 B2
6790220 Morris et al. Sep 2004 B2
6837893 Miller Jan 2005 B2
6837906 Ginn Jan 2005 B2
6846319 Ginn et al. Jan 2005 B2
6849078 Durgin et al. Feb 2005 B2
6860895 Akerfeldt et al. Mar 2005 B1
6890343 Ginn et al. May 2005 B2
6896687 Dakov May 2005 B2
6896692 Ginn et al. May 2005 B2
6904647 Byers, Jr. Jun 2005 B2
6913607 Ainsworth et al. Jul 2005 B2
6926723 Mulhauser et al. Aug 2005 B1
6926731 Coleman et al. Aug 2005 B2
6929634 Dorros et al. Aug 2005 B2
6942641 Seddon Sep 2005 B2
6942674 Belef et al. Sep 2005 B2
6942691 Chuter Sep 2005 B1
6964668 Modesitt et al. Nov 2005 B2
6969391 Gazzani Nov 2005 B1
6969397 Ginn Nov 2005 B2
6984238 Gifford, III et al. Jan 2006 B2
6989003 Wing et al. Jan 2006 B2
6989016 Tallarida et al. Jan 2006 B2
7001398 Carley et al. Feb 2006 B2
7001400 Modesitt et al. Feb 2006 B1
7008435 Cummins Mar 2006 B2
7008439 Janzen et al. Mar 2006 B1
7025776 Houser et al. Apr 2006 B1
7033379 Peterson Apr 2006 B2
7060084 Loshakove et al. Jun 2006 B1
7063711 Loshakove et al. Jun 2006 B1
7074232 Kanner et al. Jul 2006 B2
7076305 Imran et al. Jul 2006 B2
7083635 Ginn Aug 2006 B2
7087064 Hyde Aug 2006 B1
7087088 Berg et al. Aug 2006 B2
7108709 Cummins Sep 2006 B2
7111768 Cummins et al. Sep 2006 B2
7112225 Ginn Sep 2006 B2
7144411 Ginn et al. Dec 2006 B2
7163551 Anthony et al. Jan 2007 B2
7169158 Sniffin et al. Jan 2007 B2
7169164 Borillo et al. Jan 2007 B2
7211101 Carley et al. May 2007 B2
7220268 Blatter May 2007 B2
7261716 Strobel et al. Aug 2007 B2
7306614 Weller et al. Dec 2007 B2
7311720 Mueller et al. Dec 2007 B2
7316704 Bagaoisan et al. Jan 2008 B2
7316706 Bloom et al. Jan 2008 B2
7322995 Buckman et al. Jan 2008 B2
7326230 Ravikumar Feb 2008 B2
7331979 Khosravi et al. Feb 2008 B2
7335220 Khosravi et al. Feb 2008 B2
D566272 Walberg et al. Apr 2008 S
7361178 Hearn et al. Apr 2008 B2
7361183 Ginn Apr 2008 B2
7361185 O'Malley et al. Apr 2008 B2
7393363 Ginn Jul 2008 B2
7396359 Derowe et al. Jul 2008 B1
7431729 Chanduszko Oct 2008 B2
7445596 Kucklick et al. Nov 2008 B2
7465286 Patterson et al. Dec 2008 B2
7533790 Knodel et al. May 2009 B1
7556632 Zadno Jul 2009 B2
7582103 Young et al. Sep 2009 B2
7582104 Corcoran et al. Sep 2009 B2
7597706 Kanner et al. Oct 2009 B2
7618427 Ortiz et al. Nov 2009 B2
7622628 Bergin et al. Nov 2009 B2
7645285 Cosgrove et al. Jan 2010 B2
D611144 Reynolds Mar 2010 S
7678135 Maahs et al. Mar 2010 B2
7780696 Daniel et al. Aug 2010 B2
7799042 Williamson, IV et al. Sep 2010 B2
7806904 Carley et al. Oct 2010 B2
7819895 Ginn et al. Oct 2010 B2
7824419 Boraiah Nov 2010 B2
7841502 Walberg et al. Nov 2010 B2
7842068 Ginn Nov 2010 B2
7850709 Cummins et al. Dec 2010 B2
7850797 Carley et al. Dec 2010 B2
7854810 Carley et al. Dec 2010 B2
7857828 Jabba et al. Dec 2010 B2
7867249 Palermo et al. Jan 2011 B2
7875054 LaFontaine Jan 2011 B2
7879071 Carley et al. Feb 2011 B2
7887555 Carley et al. Feb 2011 B2
7887563 Cummins et al. Feb 2011 B2
7901428 Ginn et al. Mar 2011 B2
7905900 Palermo Mar 2011 B2
7918873 Cummins et al. Apr 2011 B2
7931669 Ginn et al. Apr 2011 B2
7931671 Tenerz Apr 2011 B2
7967842 Bakos Jun 2011 B2
8007512 Ginn et al. Aug 2011 B2
8103327 Harlev et al. Jan 2012 B2
8105352 Egnelöv Jan 2012 B2
8172749 Melsheimer May 2012 B2
8216260 Lam et al. Jul 2012 B2
8226666 Zarbatany et al. Jul 2012 B2
8403929 Weisshaupt et al. Mar 2013 B2
8409228 Blatter et al. Apr 2013 B2
8562630 Campbell Oct 2013 B2
8834494 Schorr et al. Sep 2014 B2
8992549 Bennett, III Mar 2015 B2
20010007077 Ginn et al. Jul 2001 A1
20010021855 Levinson Sep 2001 A1
20010031972 Robertson et al. Oct 2001 A1
20010031973 Nobles et al. Oct 2001 A1
20010044639 Levinson Nov 2001 A1
20010046518 Sawhney Nov 2001 A1
20010047180 Grudem et al. Nov 2001 A1
20020022822 Cragg et al. Feb 2002 A1
20020026215 Redmond et al. Feb 2002 A1
20020026216 Grimes Feb 2002 A1
20020029050 Gifford, III et al. Mar 2002 A1
20020038127 Blatter et al. Mar 2002 A1
20020042622 Vargas et al. Apr 2002 A1
20020049427 Wiener et al. Apr 2002 A1
20020049453 Nobles et al. Apr 2002 A1
20020058960 Hudson et al. May 2002 A1
20020062104 Ashby et al. May 2002 A1
20020077657 Ginn et al. Jun 2002 A1
20020082641 Ginn et al. Jun 2002 A1
20020095164 Andreas et al. Jul 2002 A1
20020095181 Beyar Jul 2002 A1
20020099389 Michler et al. Jul 2002 A1
20020106409 Sawhney et al. Aug 2002 A1
20020107542 Kanner et al. Aug 2002 A1
20020151921 Kanner et al. Oct 2002 A1
20020151963 Brown et al. Oct 2002 A1
20020169475 Gainor et al. Nov 2002 A1
20020183786 Girton Dec 2002 A1
20020183787 Wahr et al. Dec 2002 A1
20020198562 Akerfeldt et al. Dec 2002 A1
20020198589 Leong Dec 2002 A1
20030004543 Gleeson et al. Jan 2003 A1
20030009180 Hinchliffe et al. Jan 2003 A1
20030018358 Saadat Jan 2003 A1
20030023248 Parodi Jan 2003 A1
20030032981 Kanner et al. Feb 2003 A1
20030033006 Phillips et al. Feb 2003 A1
20030045893 Ginn Mar 2003 A1
20030055455 Yang et al. Mar 2003 A1
20030060846 Egnelov et al. Mar 2003 A1
20030065358 Frecker et al. Apr 2003 A1
20030083679 Grudem et al. May 2003 A1
20030093096 McGuckin et al. May 2003 A1
20030093108 Avellanet et al. May 2003 A1
20030097140 Kanner May 2003 A1
20030109890 Kanner et al. Jun 2003 A1
20030125766 Ding Jul 2003 A1
20030139819 Beer et al. Jul 2003 A1
20030144695 McGuckin, Jr. et al. Jul 2003 A1
20030158577 Pantages et al. Aug 2003 A1
20030158578 Pantages et al. Aug 2003 A1
20030167063 Kerr Sep 2003 A1
20030195504 Tallarida et al. Oct 2003 A1
20030208211 Kortenbach Nov 2003 A1
20040002763 Phillips et al. Jan 2004 A1
20040009205 Sawhney Jan 2004 A1
20040044350 Martin et al. Mar 2004 A1
20040049224 Buehlmann et al. Mar 2004 A1
20040059376 Breuniger Mar 2004 A1
20040068273 Fariss et al. Apr 2004 A1
20040073236 Carley et al. Apr 2004 A1
20040078053 Berg et al. Apr 2004 A1
20040082906 Tallarida et al. Apr 2004 A1
20040087985 Loshakove et al. May 2004 A1
20040092962 Thornton et al. May 2004 A1
20040092964 Modesitt et al. May 2004 A1
20040092968 Caro et al. May 2004 A1
20040092973 Chanduszko et al. May 2004 A1
20040093024 Lousararian et al. May 2004 A1
20040093027 Fabisiak et al. May 2004 A1
20040097978 Modesitt et al. May 2004 A1
20040106980 Solovay et al. Jun 2004 A1
20040127940 Ginn et al. Jul 2004 A1
20040143290 Brightbill Jul 2004 A1
20040143291 Corcoran et al. Jul 2004 A1
20040153122 Palermo Aug 2004 A1
20040158127 Okada Aug 2004 A1
20040158287 Cragg et al. Aug 2004 A1
20040158309 Wachter et al. Aug 2004 A1
20040167511 Buehlmann et al. Aug 2004 A1
20040167570 Pantages et al. Aug 2004 A1
20040191277 Sawhney et al. Sep 2004 A1
20040215232 Belhe et al. Oct 2004 A1
20040243216 Gregorich Dec 2004 A1
20040249412 Snow et al. Dec 2004 A1
20040254591 Kanner et al. Dec 2004 A1
20040267193 Bagaoisan et al. Dec 2004 A1
20040267308 Bagaoisan et al. Dec 2004 A1
20040267312 Kanner et al. Dec 2004 A1
20050038460 Jayaraman Feb 2005 A1
20050038500 Boylan et al. Feb 2005 A1
20050059982 Zung et al. Mar 2005 A1
20050075654 Kelleher Apr 2005 A1
20050075665 Brenzel et al. Apr 2005 A1
20050085851 Fiehler et al. Apr 2005 A1
20050085854 Ginn Apr 2005 A1
20050085855 Forsberg Apr 2005 A1
20050090859 Ravlkumar Apr 2005 A1
20050119695 Carley et al. Jun 2005 A1
20050121042 Belhe et al. Jun 2005 A1
20050148818 Mesallum Jul 2005 A1
20050149117 Khosravi et al. Jul 2005 A1
20050152949 Hotchkiss et al. Jul 2005 A1
20050154401 Weldon et al. Jul 2005 A1
20050165357 McGuckin et al. Jul 2005 A1
20050169974 Tenerz et al. Aug 2005 A1
20050177189 Ginn et al. Aug 2005 A1
20050187564 Jayaraman Aug 2005 A1
20050203552 Laufer et al. Sep 2005 A1
20050216057 Coleman et al. Sep 2005 A1
20050222614 Ginn et al. Oct 2005 A1
20050228443 Yassinzadeh Oct 2005 A1
20050245876 Khosravi et al. Nov 2005 A1
20050256532 Nayak et al. Nov 2005 A1
20050267524 Chanduszko Dec 2005 A1
20050267528 Ginn et al. Dec 2005 A1
20050273136 Belef et al. Dec 2005 A1
20050273137 Ginn Dec 2005 A1
20050274768 Cummins et al. Dec 2005 A1
20050283188 Loshakove et al. Dec 2005 A1
20060030867 Zadno Feb 2006 A1
20060034930 Khosravi et al. Feb 2006 A1
20060047313 Khanna et al. Mar 2006 A1
20060058844 White et al. Mar 2006 A1
20060064115 Allen et al. Mar 2006 A1
20060100664 Pai et al. May 2006 A1
20060142784 Kontos Jun 2006 A1
20060167484 Carley et al. Jul 2006 A1
20060190014 Ginn et al. Aug 2006 A1
20060190036 Wendel et al. Aug 2006 A1
20060190037 Ginn et al. Aug 2006 A1
20060190038 Carley et al. Aug 2006 A1
20060195123 Ginn et al. Aug 2006 A1
20060195124 Ginn et al. Aug 2006 A1
20060195125 Sakakine et al. Aug 2006 A1
20060206146 Tenerz Sep 2006 A1
20060229553 Hammack et al. Oct 2006 A1
20060253037 Ginn et al. Nov 2006 A1
20060253072 Pai et al. Nov 2006 A1
20060287673 Brett et al. Dec 2006 A1
20060287674 Ginn et al. Dec 2006 A1
20060293698 Douk Dec 2006 A1
20070005093 Cox Jan 2007 A1
20070010851 Chanduszko et al. Jan 2007 A1
20070010853 Ginn et al. Jan 2007 A1
20070021778 Carly Jan 2007 A1
20070027476 Harris et al. Feb 2007 A1
20070027525 Ben-Muvhar Feb 2007 A1
20070049968 Sibbitt, Jr. et al. Mar 2007 A1
20070049970 Belef et al. Mar 2007 A1
20070060895 Sibbitt, Jr. et al. Mar 2007 A1
20070060950 Khosravi et al. Mar 2007 A1
20070060951 Shannon Mar 2007 A1
20070073337 Abbott et al. Mar 2007 A1
20070078302 Ortiz et al. Apr 2007 A1
20070083230 Javois Apr 2007 A1
20070083231 Lee Apr 2007 A1
20070093869 Bloom et al. Apr 2007 A1
20070112304 Voss May 2007 A1
20070112365 Hilal et al. May 2007 A1
20070112385 Conlon May 2007 A1
20070123816 Zhu et al. May 2007 A1
20070123817 Khosravi et al. May 2007 A1
20070123936 Goldin et al. May 2007 A1
20070149996 Coughlin Jun 2007 A1
20070167981 Opolski et al. Jul 2007 A1
20070172430 Brito et al. Jul 2007 A1
20070179527 Eskuri et al. Aug 2007 A1
20070185529 Coleman et al. Aug 2007 A1
20070185530 Chin-Chen et al. Aug 2007 A1
20070203507 McLaughlin et al. Aug 2007 A1
20070213747 Monassevitch et al. Sep 2007 A1
20070225755 Preinitz et al. Sep 2007 A1
20070225756 Preinitz et al. Sep 2007 A1
20070225757 Preinitz et al. Sep 2007 A1
20070225758 Preinitz et al. Sep 2007 A1
20070239209 Fallman Oct 2007 A1
20070250080 Jones et al. Oct 2007 A1
20070265658 Nelson et al. Nov 2007 A1
20070270904 Ginn Nov 2007 A1
20070275036 Green, III et al. Nov 2007 A1
20070276416 Ginn et al. Nov 2007 A1
20070276488 Wachter et al. Nov 2007 A1
20070282352 Carley et al. Dec 2007 A1
20070282373 Ashby et al. Dec 2007 A1
20080004636 Walberg et al. Jan 2008 A1
20080004640 Ellingwood Jan 2008 A1
20080009794 Bagaoisan et al. Jan 2008 A1
20080033459 Shafi et al. Feb 2008 A1
20080045979 Ma Feb 2008 A1
20080058839 Nobles et al. Mar 2008 A1
20080065151 Ginn Mar 2008 A1
20080065152 Carley Mar 2008 A1
20080082123 Forsberg et al. Apr 2008 A1
20080086075 Isik et al. Apr 2008 A1
20080091235 Sirota Apr 2008 A1
20080093414 Bender et al. Apr 2008 A1
20080097509 Beyar et al. Apr 2008 A1
20080114378 Matsushita May 2008 A1
20080114395 Mathisen et al. May 2008 A1
20080177288 Carlson Jul 2008 A1
20080208225 Seibold et al. Aug 2008 A1
20080210737 Ginn et al. Sep 2008 A1
20080221616 Ginn et al. Sep 2008 A1
20080243148 Mikkaichi et al. Oct 2008 A1
20080243182 Bates et al. Oct 2008 A1
20080249504 Lattouf et al. Oct 2008 A1
20080269801 Coleman et al. Oct 2008 A1
20080269802 Coleman et al. Oct 2008 A1
20080272173 Coleman et al. Nov 2008 A1
20080287988 Smith et al. Nov 2008 A1
20080294001 Surti Nov 2008 A1
20080300628 Ellingwood Dec 2008 A1
20080312666 Ellingwood et al. Dec 2008 A1
20080312667 Drasler et al. Dec 2008 A1
20080312686 Ellingwood Dec 2008 A1
20080312740 Wachter et al. Dec 2008 A1
20080319475 Clark Dec 2008 A1
20090054912 Heanue et al. Feb 2009 A1
20090062846 Ken Mar 2009 A1
20090105728 Noda et al. Apr 2009 A1
20090112306 Bonsignore et al. Apr 2009 A1
20090132031 Cook et al. May 2009 A1
20090137900 Bonner et al. May 2009 A1
20090157101 Reyes et al. Jun 2009 A1
20090157102 Reynolds et al. Jun 2009 A1
20090171388 Dave et al. Jul 2009 A1
20090177212 Carley et al. Jul 2009 A1
20090187215 Mackiewicz et al. Jul 2009 A1
20090216267 Willard et al. Aug 2009 A1
20090221960 Albrecht et al. Sep 2009 A1
20090227938 Fasching et al. Sep 2009 A1
20090230168 Coleman et al. Sep 2009 A1
20090254119 Sibbitt, Jr. et al. Oct 2009 A1
20090259233 Bogart et al. Oct 2009 A1
20090287244 Kokish Nov 2009 A1
20090312789 Kassab et al. Dec 2009 A1
20100042118 Garrison et al. Feb 2010 A1
20100042144 Bennett Feb 2010 A1
20100114156 Mehl May 2010 A1
20100114159 Roorda et al. May 2010 A1
20100130965 Sibbitt, Jr. et al. May 2010 A1
20100160958 Clark Jun 2010 A1
20100168790 Clark Jul 2010 A1
20100179567 Voss et al. Jul 2010 A1
20100179571 Voss Jul 2010 A1
20100179572 Voss et al. Jul 2010 A1
20100179589 Roorda et al. Jul 2010 A1
20100179590 Fortson et al. Jul 2010 A1
20100185216 Garrison et al. Jul 2010 A1
20100185234 Fortson et al. Jul 2010 A1
20100217132 Ellingwood et al. Aug 2010 A1
20100249828 Mavani et al. Sep 2010 A1
20110054492 Clark Mar 2011 A1
20110060355 Carley et al. Mar 2011 A1
20110066163 Cho et al. Mar 2011 A1
20110066164 Walberg et al. Mar 2011 A1
20110071565 Ginn Mar 2011 A1
20110082495 Ruiz Apr 2011 A1
20110106148 Ginn et al. May 2011 A1
20110137340 Cummins Jun 2011 A1
20110144663 Cummins et al. Jun 2011 A1
20110144664 Jabba et al. Jun 2011 A1
20110144668 Carley et al. Jun 2011 A1
20110144691 Cummins Jun 2011 A1
20110166584 Palermo et al. Jul 2011 A1
20110178548 Tenerz Jul 2011 A1
20110218568 Voss Sep 2011 A1
20110224719 Fortson Sep 2011 A1
20110230897 Palermo et al. Sep 2011 A1
20110238089 Reyes et al. Sep 2011 A1
20110270282 Lemke Nov 2011 A1
20110288563 Gianotti et al. Nov 2011 A1
20120035630 Roorda Feb 2012 A1
20120101520 Ginn et al. Apr 2012 A1
20120245603 Voss Sep 2012 A1
20120245623 Kariniemi et al. Sep 2012 A1
20120245626 Ellingwood et al. Sep 2012 A1
20120310261 Cummins et al. Dec 2012 A1
20130006274 Walberg et al. Jan 2013 A1
20130053792 Fischell et al. Feb 2013 A1
20130310853 Zaugg et al. Nov 2013 A1
20130338708 Cummins et al. Dec 2013 A1
20140005692 Ellingwood et al. Jan 2014 A1
20140018850 Ellingwood Jan 2014 A1
20140142624 Pantages et al. May 2014 A1
20140180311 Voss Jun 2014 A1
20140309686 Ginn et al. Oct 2014 A1
20150265279 Walberg et al. Sep 2015 A1
Foreign Referenced Citations (141)
Number Date Country
2003297432 Jul 2004 AU
2 339 060 Feb 2000 CA
197 11 288 Oct 1998 DE
29723736 Apr 1999 DE
19859952 Feb 2000 DE
102006056283 Jun 2008 DE
0 386 361 Sep 1990 EP
0 534 696 Mar 1993 EP
0 621 032 Oct 1994 EP
0 756 851 Feb 1997 EP
0 774 237 May 1997 EP
0 858 776 Aug 1998 EP
0 941 697 Sep 1999 EP
1 867 287 Dec 2007 EP
2 443 238 Jul 1980 FR
2 715 290 Jul 1995 FR
2 722 975 Feb 1996 FR
2 768 324 Mar 1999 FR
1 358 466 Jul 1974 GB
2 075 144 Nov 1981 GB
2 397 240 Jul 2004 GB
S20000722 Oct 2001 IE
S20000724 Oct 2001 IE
S20010547 Jul 2002 IE
S20010815 Jul 2002 IE
S20010748 Aug 2002 IE
S20010749 Aug 2002 IE
S20020452 Dec 2002 IE
S20020664 Feb 2003 IE
S20020665 Feb 2003 IE
S20020451 Jul 2003 IE
S20020552 Jul 2003 IE
S20030424 Dec 2003 IE
S20030490 Jan 2004 IE
S20040368 Nov 2005 IE
S20050342 Nov 2005 IE
58-181006 Dec 1983 JP
12 74750 Nov 1989 JP
11500642 Aug 1997 JP
2000102546 Apr 2000 JP
9302140 Jul 1995 NL
171425 Apr 1997 PL
2086192 Aug 1997 RU
495067 Dec 1975 SU
912155 Mar 1982 SU
1243708 Jul 1986 SU
1324650 Jul 1987 SU
1405828 Jun 1988 SU
1456109 Feb 1989 SU
1560133 Apr 1990 SU
WO 9624291 Aug 1996 WO
WO 9700046 Jan 1997 WO
WO 9707741 Mar 1997 WO
WO 9720505 Jun 1997 WO
WO 9727897 Aug 1997 WO
WO 9806346 Feb 1998 WO
WO 9806448 Feb 1998 WO
WO 9816161 Apr 1998 WO
WO 9817179 Apr 1998 WO
WO 9818389 May 1998 WO
WO 9824374 Jun 1998 WO
WO 9825508 Jun 1998 WO
WO 9858591 Dec 1998 WO
WO 9921491 May 1999 WO
WO 9940849 Aug 1999 WO
WO 9960941 Dec 1999 WO
WO 9962408 Dec 1999 WO
WO9962408 Dec 1999 WO
WO 9962415 Dec 1999 WO
WO 0006029 Feb 2000 WO
WO 0007505 Feb 2000 WO
WO 0007640 Feb 2000 WO
WO 0027311 May 2000 WO
WO 0027313 May 2000 WO
WO0056223 Sep 2000 WO
WO 0056223 Sep 2000 WO
WO 0056227 Sep 2000 WO
WO 0056228 Sep 2000 WO
WO 0071032 Nov 2000 WO
WO 0121058 Mar 2001 WO
WO 0135832 May 2001 WO
WO 0147594 Jul 2001 WO
WO 0149186 Jul 2001 WO
WO 0191628 Dec 2001 WO
WO 0219915 Mar 2002 WO
WO 0219920 Mar 2002 WO
WO 0219922 Mar 2002 WO
WO 0219924 Mar 2002 WO
WO 0228286 Apr 2002 WO
WO 0238055 May 2002 WO
WO 0245593 Jun 2002 WO
WO 0245594 Jun 2002 WO
WO 02062234 Aug 2002 WO
WO 02098302 Dec 2002 WO
WO 03013363 Feb 2003 WO
WO 03013364 Feb 2003 WO
WO 03047434 Jun 2003 WO
WO 03071955 Sep 2003 WO
WO 03071956 Sep 2003 WO
WO 03071957 Sep 2003 WO
WO 03094748 Nov 2003 WO
WO 03101310 Dec 2003 WO
WO 2004004578 Jan 2004 WO
WO 2004012602 Feb 2004 WO
WO 2004060169 Jul 2004 WO
WO 2004069054 Aug 2004 WO
WO 2005000126 Jan 2005 WO
WO 2005006990 Jan 2005 WO
WO 2005041782 May 2005 WO
WO 2005063129 Jul 2005 WO
WO 2005082256 Sep 2005 WO
WO 2005092204 Oct 2005 WO
WO 2005110240 Nov 2005 WO
WO 2005112782 Dec 2005 WO
WO 2005115251 Dec 2005 WO
WO 2005115521 Dec 2005 WO
WO 2006000514 Jan 2006 WO
WO 2006026116 Mar 2006 WO
WO 2006052611 May 2006 WO
WO 2006052612 May 2006 WO
WO 2006078578 Jul 2006 WO
WO 2006083889 Aug 2006 WO
WO 2006115901 Nov 2006 WO
WO 2006115904 Nov 2006 WO
WO 2006118877 Nov 2006 WO
WO 2007005585 Jan 2007 WO
WO 2007025014 Mar 2007 WO
WO 2007081836 Jul 2007 WO
WO 2007088069 Aug 2007 WO
WO 2008031102 Mar 2008 WO
WO 2008036384 Mar 2008 WO
WO 2008074027 Jun 2008 WO
WO 2008150915 Dec 2008 WO
WO 2009079091 Jun 2009 WO
WO 2010062693 Jun 2010 WO
WO 2010081101 Jul 2010 WO
WO 2010081102 Jul 2010 WO
WO 2010081103 Jul 2010 WO
WO 2010081106 Jul 2010 WO
200100527 Jan 2001 ZA
200100528 Jan 2001 ZA
Non-Patent Literature Citations (659)
Entry
U.S. Appl. No. 13/791,829, filed Mar. 8, 2013, Roorda et al.
U.S. Appl. No. 13/791,846, filed Mar. 8, 2013, Palermo.
U.S. Appl. No. 11/744,089, Apr. 15, 2013, Office Action.
U.S. Appl. No. 13/112,618, Mar. 29, 2013, Office Action.
U.S. Appl. No. 13/112,631, Mar. 29, 2013, Office Action.
U.S. Appl. No. 13/308,227, Apr. 10, 2013, Office Action.
U.S. Appl. No. 13/525,839, Apr. 1, 2013, Office Action.
U.S. Appl. No. 13/615,547, Apr. 12, 2013, Notice of Allowance.
U.S. Appl. No. 12/548,274, Sep. 10, 2012, Office Action.
U.S. Appl. No. 12/608,769, Aug. 22, 2012, Office Action.
U.S. Appl. No. 12/642,319, Aug. 28, 2012, Office Action.
U.S. Appl. No. 12/684,470, Aug. 30, 2012, Office Action.
U.S. Appl. No. 12/684,542, Sep. 13, 2012, Office Action.
U.S. Appl. No. 12/987,792, Sep. 17, 2012, Office Action.
U.S. Appl. No. 12/402,398, Sep. 20, 2012, Office Action.
U.S. Appl. No. 12/684,400, Oct. 16, 2012, Office Action.
U.S. Appl. No. 12/688,065, Oct. 12, 2012, Office Action.
U.S. Appl. No. 12/848,642, Sep. 20, 2012, Office Action.
U.S. Appl. No. 11/767,818, Feb. 3, 2012, Notice of Allowance.
U.S. Appl. No. 12/684,542, Jan. 30, 2012, Restriction Requirement.
U.S. Appl. No. 12/941,809, Jan. 30, 2012, Office Action.
U.S. Appl. No. 12/966,923, Feb. 3, 2012 Notice of Allowance.
U.S. Appl. No. 11/344,891, Jan. 22, 2013, Notice of Allowance.
U.S. Appl. No. 12/961,331, Feb. 1, 2013, Office Action
U.S. Appl. No. 13/030,922, Jan. 31, 2013, Office Action.
U.S. Appl. No. 13/153,594, Jan. 29, 2013, Office Action.
U.S. Appl. No. 13/488,233, Feb. 5, 2013, Notice of Allowance.
U.S. Appl. No. 13/615,547, Jan. 18, 2013, Office Action.
U.S. Appl. No. 12/113,851, Mar. 29, 2012, Office Action.
U.S. Appl. No. 12/114,091, Apr. 5, 2012, Office Action.
U.S. Appl. No. 12/403,277, Apr. 3, 2012, Office Action.
U.S. Appl. No. 12/684,470, Mar. 23, 2012, Office Action.
U.S. Appl. No. 12/688,065, Mar. 13, 2012, Office Action.
U.S. Appl. No. 12/987,792, Mar. 13, 2012, Office Action.
U.S. Appl. No. 12/143,020, May 30, 2012, Issue Notification.
U.S. Appl. No. 12/393,877, May 21, 2012, Office Action.
U.S. Appl. No. 12/608,773, Jun. 7, 2012, Office Action.
U.S. Appl. No. 12/684,400, May 9, 2012, Office Action.
U.S. Appl. No. 12/941,809, Jun. 1, 2012, Office Action.
U.S. Appl. No. 12/945,646, May 30, 2012, Issue Notification.
U.S. Appl. No. 12/973,204, May 30, 2012, Issue Notification.
U.S. Appl. No. 13/026,989, Jun. 8, 2012, Office Action
U.S. Appl. No. 13/525,839, filed Jun. 18, 2012, Carley et al.
U.S. Appl. No. 11/427,297, Jun. 26, 2012, Notice of Allowance.
U.S. Appl. No. 11/767,818, Jul. 4, 2012, Issue Notification.
U.S. Appl. No. 12/338,977, Jul. 11, 2012, Office Action.
U.S. Appl. No. 11/427,297, Oct. 31, 2012, Issue Notification.
U.S. Appl. No. 12/114,091, Nov. 8, 2012, Office Action.
U.S. Appl. No. 12/403,277, Nov. 5, 2012, Office Action.
U.S. Appl. No. 12/608,769, Nov. 5, 2012, Notice of Allowance.
U.S. Appl. No. 12/848,642, Nov. 9, 2012, Office Action.
U.S. Appl. No. 12/850,242, Oct. 17, 2012, Office Action.
U.S. Appl. No. 13/039,087, Nov. 6, 2012, Notice of Allowance.
U.S. Appl. No. 12/338,977, Nov. 28, 2012, Office Action.
U.S. Appl. No. 12/961,331, Dec. 4, 2012, Office Action.
U.S. Appl. No. 13/030,922, Dec. 18, 2012, Office Action.
U.S. Appl. No. 60/693,531, filed Jun. 24, 2005, Carly.
U.S. Appl. No. 12/114,031, Mar. 6, 2012, Office Action.
U.S. Appl. No. 12/135,858, Feb. 16, 2012, Office Action.
U.S. Appl. No. 12/143,020, Feb. 23, 2012, Notice of Allowance.
U.S. Appl. No. 12/548,274, Mar. 2, 2012, Office Action.
U.S. Appl. No. 12/608,769, Feb. 10, 2012, Office Action.
U.S. Appl. No. 12/642,319, Feb. 27, 2012, Office Action.
U.S. Appl. No. 12/684,400, Feb. 13, 2012, Office Action.
U.S. Appl. No. 12/684,562, Feb. 16, 2012, Office Action.
U.S. Appl. No. 12/724,304, Feb. 10, 2012, Office Action.
U.S. Appl. No. 12/897,358, Mar. 5, 2012, Notice of Allowance.
U.S. Appl. No. 12/945,646, Feb. 21, 2012, Notice of Allowance.
U.S. Appl. No. 12/973,204, Mar. 7, 2012, Notice of Allowance.
U.S. Appl. No. 12/402,398, Mar. 13, 2013, Notice of Allowance.
U.S. Appl. No. 13/308,227, filed Nov. 30, 2011, Yibarren.
U.S. Appl. No. 11/390,586, May 3, 2012, Notice of Allowance.
U.S. Appl. No. 12/684,542, Apr. 16, 2012, Office Action.
U.S. Appl. No. 12/688,065, Apr. 26, 2012, Office Action.
U.S. Appl. No. 12/897,358, May 2, 2012, Issue Notification.
U.S. Appl. No. 11/344,891, May 15, 2013, Issue Notification.
U.S. Appl. No. 11/396,141, Apr. 30, 2013, Office Action.
U.S. Appl. No. 11/852,190, Apr. 24, 2013, Office Action.
U.S. Appl. No. 12/848,642, Apr. 26, 2013, Office Action.
U.S. Appl. No. 12/850,242, Apr. 18, 2013, Office Action.
U.S. Appl. No. 12/955,859, May 16, 2013, Office Action.
U.S. Appl. No. 13/052,634, Feb. 8, 2013, Office Action.
U.S. Appl. No. 13/052,634, Apr. 22, 2013, Office Action.
U.S. Appl. No. 13/488,233, May 15, 2013, Issue Notification.
U.S. Appl. No. 13/490,143, Apr. 29, 2013, Notice of Allowance.
U.S. Appl. No. 13/898,202, filed May 20, 2013, Walberg et al.
U.S. Appl. No. 11/427,309, Jun. 7, 2013, Notice of Allowance.
U.S. Appl. No. 13/112,618, Jun. 7, 2013, Office Action.
U.S. Appl. No. 13/153,594, May 29, 2013, Office Action.
U.S. Appl. No. 13/488,233, Jun. 5, 2013, Issue Notification.
U.S. Appl. No. 13/791,829, May 29, 2013, Office Action.
U.S. Appl. No. 10/786,444, Jul. 11, 2013, Notice of Allowance.
U.S. Appl. No. 10/908,721, Jul. 18, 2013, Notice of Allowance.
U.S. Appl. No. 11/532,325, Jul. 17, 2013, Office Action.
U.S. Appl. No. 12/106,928, Jun. 28, 2013, Office Action.
U.S. Appl. No. 12/106,937, Jun. 28, 2013, Office Action.
U.S. Appl. No. 12/338,977, Jun. 19, 2013, Office Action.
U.S. Appl. No. 12/941,809, Jul. 3, 2013, Office Action.
U.S. Appl. No. 12/961,331, Jul. 3, 2013, Office Action.
U.S. Appl. No. 13/030,922, Jul. 18, 2013, Office Action.
U.S. Appl. No. 13/112,631, Jun. 26, 2013, Office Action.
U.S. Appl. No. 13/525,839, Jul. 15, 2013, Notice of Allowance.
U.S. Appl. No. 13/615,547, Jul. 10, 2013, Issue Notification.
U.S. Appl. No. 11/675,462, Aug. 15, 2012, Issue Notification.
U.S. Appl. No. 11/744,089, Aug. 8, 2012, Office Action.
U.S. Appl. No. 12/481,377, Aug. 10, 2012, Notice of Allowance.
U.S. Appl. No. 12/608,773, Jul. 20, 2012, Office Action.
U.S. Appl. No. 12/684,562, Aug. 21, 2012, Office Action.
U.S. Appl. No. 12/684,569, Jul. 30, 2012, Office Action.
U.S. Appl. No. 12/850,242, Aug. 6, 2012, Office Action.
U.S. Appl. No. 12/955,859, Aug. 6, 2012, Office Action.
U.S. Appl. No. 13/039,087, Jul. 17, 2012, Office Action.
U.S. Appl. No. 11/396,141, Aug. 21, 2013, Office Action.
U.S. Appl. No. 11/744,089, Aug. 8, 2013, Notice of Allowance.
U.S. Appl. No. 12/850,242, Aug. 6, 2013, Notice of Allowance.
U.S. Appl. No. 12/955,859, Aug. 1, 2013, Notice of Allowance.
U.S. Appl. No. 13/026,989, Aug. 23, 2013, Office Action.
U.S. Appl. No. 13/490,143, Aug. 21, 2013, Issue Notification.
U.S. Appl. No. 13/615,547, Aug. 7, 2013, Issue Notification.
U.S. Appl. No. 12/338,977, Jan. 19, 2012, Office Action.
U.S. Appl. No. 12/684,569, Jan. 27, 2012, Office Action.
U.S. Appl. No. 09/610,128, filed Jul. 5, 2000, Kerievsky.
U.S. Appl. No. 09/866,551, filed May 25, 2001, Ginn.
U.S. Appl. No. 12/113,092, filed Apr. 30, 2008, Ginn et al.
U.S. Appl. No. 12/848,642, filed Aug. 2, 2010, Fortson et al.
U.S. Appl. No. 12/961,331, filed Dec. 6, 2010, Voss.
U.S. Appl. No. 13/017,636, filed Jan. 31, 2011, Carley et al.
U.S. Appl. No. 60/696,069, filed Jul. 1, 2005, Pantages et al.
U.S. Appl. No. 60/793,444, filed Apr. 20, 2006, Jones et al.
U.S. Appl. No. 60/946,026, filed Jun. 25, 2007, Ellingwood.
U.S. Appl. No. 60/946,030, filed Jun. 25, 2007, Voss et al.
U.S. Appl. No. 60/946,042, filed Jun. 25, 2007, Ellingwood et al.
U.S. Appl. No. 61/015,144, filed Dec. 19, 2007, Mackiewicz et al.
U.S. Appl. No. 61/109,822, filed Oct. 30, 2008, Mehl et al.
U.S. Appl. No. 61/139,995, filed Dec. 22, 2008, Clark.
U.S. Appl. No. 61/141,597, filed Dec. 30, 2008, Clark.
U.S. Appl. No. 61/143,748, filed Jan. 9, 2009, Mehl et al.
U.S. Appl. No. 61/143,751, filed Jan. 9, 2009, Voss et al.
U.S. Appl. No. 61/145,468, filed Jan. 16, 2009, Fortson, et al.
“Hand tool for forming telephone connections—comprises pliers with reciprocably driven ram crimping clip around conductors against anvil”, Derwent-ACC-No. 1978-B8090A.
Database WPI; Section PQ, Week 200120; Derwent Publications Ltd., London GB; Class P31, AN 2001-203165; XP002199926 & ZA 200 100 528 A (Anthony T), Feb. 28, 2001 abstract.
Deepak Mital et al, Renal Transplantation Without Sutures Using the Vascular Clipping System for Renal Artery and Vein Anastomosis—A New Technique, Transplantation Issue, Oct. 1996, pp. 1171-1173, vol. 62—No. 8, Section of Transplantation Surgery, Department of General Surgery, Rush-Presbyterian/St. Luke's Medical Center, Chigago, IL.
DL Wessel et al, Outpatient closure of the patent ductus arteriosus, Circulation, May 1988, pp. 1068-1071, vol. 77—No. 5, Department of Anesthesia, Children's Hospital, Boston, MA.
E Pikoulis et al, Arterial reconstruction with vascular clips is safe and quicker than sutured repair, Cardiovascular Surgery, Dec. 1998, pp. 573-578(6), vol. 6—No. 6, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD.
G Gershony et al, Novel vascular sealing device for closure of percutaneous vascular access sites, Cathet. Cardiovasc. Diagn., Jan. 1998, pp. 82-88, vol. 45.
H De Swart et al, A new hemostatic puncture closure device for the immediate sealing of arterial puncture sites, American journal of cardiology, Aug. 1993, pp. 445-449, vol. 72—No. 5, Department of Cardiology, Academic Hospital Maastricht, The Netherlands.
Harrith M. Hasson M.D. , Laparoscopic Cannula Cone with Means for Cannula Stabilization and Wound Closure, The Journal of the American Association of Gynecologic Laparoscopists, May 1998, pp. 183-185, vol. 5—No. 2, Division of Obstetrics and Gynecology, University of Chicago, Chigago, IL.
J. Findlay et al, Carotid Arteriotomy Closure Using a Vascular Clip System, Neurosurgery, Mar. 1998, pp. 550-554, vol. 42—No. 3, Division of Neurosurgery, University of Alberta, Edmonton, Canada.
Jeremy L Gilbert PhD, Wound Closure Biomaterials and Devices, Shock., Mar. 1999, p. 226, vol. 11—No. 3, Institution Northwestern University (editorial review).
Jochen T. Cremer, MD, et al, Different approaches for minimally invasive closure of atrial septal defects, Ann. Thorac. Surg., Nov. 1998, pp. 1648-1652, vol. 67, a Division of Thoracic and Cardiovascular Surgery, Surgical Center, Hannover Medical School. Hannover, Germany.
K Narayanan et al, Simultaneous primary closure of four fasciotomy wounds in a single setting using the Sure-Closure device, Injury, Jul. 1996, pp. 449-451, vol. 27—No. 6, Department of Surgery, Mercy Hospital of Pittsburgh, PA.
Marshall A.C., Lock J.E., Structural and Compliant Anatomy of the Patent Foramen Ovale in Patients Undergoing Transcatheter Closure, Am Heart J Aug. 2000; 140(2); pp. 303-307.
MD Gonze et al, Complications associated with percutaneous closure devices, Conference: Annual Meeting of the Society for Clinical Vascular Surgery, The American journal of surgery, Mar. 1999, pp. 209-211, vol. 178, No. 3, Department of Surgery, Section of Vascular Surgery, Ochsner Medical Institutions, New Orleans, LA.
MD Hellinger et al, Effective peritoneal and fascial closure of abdominal trocar sites utilizing the Endo-Judge, J Laparoendosc Surg., Oct. 1996, pp. 329-332, vol. 6—No. 5, Orlando Regional Medical Center, FL.
Michael Gianturco, A Play on Catheterization, Forbes, Dec. 1996, p. 146, vol. 158—No. 15.
Inlet Medical Inc. Brochure, pp. 1-2, referencing Om Elashry et al, Comparative clinical study of port-closure techniques following laparoscopic surgery, Department of Surgery, Mallickrodt Institute of Radiography, J Am Coll Surg., Oct. 1996, pp. 335-344, vol. 183—No. 4.
P M N Werker, et al, Review of facilitated approaches to vascular anastomosis surgery, Conference: Utrecht MICABG Workshop 2, The Annals of thoracic surgery, Apr. 1996, pp. S122-S127, vol. 63—No. 6, Department of Plastic, Reconstructive and Hand surgery, University Hospital Utrecht Netherlands Departments of Cardiology and Cardiopulmonary Surgery, Heart Lung Institute, Utrecht Netherlands.; Utrect University Hospital Utrecht Netherlands.
Peter Rhee MD et al, Use of Titanium Vascular Staples in Trauma, Journal of Trauma—Injury Infection & Critical Care, Dec. 1998, pp. 1097-1099, vol. 45—No. 6, Institution from the Department of Surgery, Washington Hospital Center, Washington DC, and Uniformed Services University of the Health Sciences, Bethesda, Maryland.
ProstarXL—Percutaneous Vascular Surgical Device, www.Archive.org, Jun. 1998, Original Publisher: http://prostar.com, may also be found at http://web.archive.org/web/19980630040429/www.perclose.com/html/prstrxl.html.
SA Beyer-Enke et al, Immediate sealing of arterial puncture site following femoropopliteal angioplasty: A prospective randomized trial, Cardiovascular and Interventional Radiology 1996, Nov.-Dec. 1996, pp. 406-410, vol. 19—No. 6, Gen Hosp North, Dept Dianost & Intervent Radiol, Nurnberg, Germany (Reprint).
Scott Hensley, Closing Wounds. New Devices seal arterial punctures in double time, Modern Healthcare (United States), Mar. 23, 2008, p. 48.
Sigmund Silber et al, A novel vascular device for closure of percutaneous arterial access sites, The American Journal of Cardiology, Apr. 1999, pp. 1248-1252, vol. 83—No. 8.
Simonetta Blengino et al, A Randomized Study of the 8 French Hemostatic Puncture Closure Device vs Manual Compression After Coronary Interventions, Journal of the American College of Cardiology, Feb. 1995, p. 262A, vol. 25.—No. 2, Supplement 1.
Stretch Comb by Scunci, retrieved via internet at www.scunci.com/productdetail by examiner on Oct. 9, 2007, publication date unavailable.
Swee Lian Tan, MD, PhD, FACS, Explanation of Infected Hemostatic Puncture Closure Devices—A Case Report, Vascular and Endovascular Surgery, 1999, pp. 507-510, vol. 33—No. 5, Parkland Medical Center, Derry, New Hampshire.
SY Nakada et al, Comparison of newer laparoscopic port closure techniques in the porcine model, J Endourol, Oct. 1995, pp. 397-401, vol. 9—No. 5, Department of Surgery/Urology, University of Wisconsin Medical School, Madison.
Taber's Cyclopedic Medical Dictionary, 18th Ed. 1997, pp. 747 and 1420.
Thomas P. Baum RPA-C et al, Delayed Primary Closure Using Silastic Vessel Loops and Skin Staples: Description of the Technique and Case Reports, Annals of Plastic Surgery, Mar. 1999, pp. 337-340, vol. 42—No. 3, Institution Department of Plastic and Reconstructive Surgery, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY.
Tomoaki Hinohara, Percutaneous vascular surgery (Prostar® Plus and Techstar® for femoral artery site closure), Interventional Cardiology Newsletter, May-Jul. 1997, pp. 19-22, pp. 242-8, vol. 5—No. 3-4.
UT Aker et al, Immediate arterial hemostasis after cardiac catheterization: initial experience with a new puncture closure device, Cathet Cardiovasc Diagn, Mar. 1994, pp. 228-232, vol. 33—No. 3, Missouri Baptist Medical Center, St. Louis.
Wei Qu et al, An absorbable pinned-ring device for microvascular anastomosis of vein grafts: Experimental studies, Microsurgery 1999, Mar. 1999, pp. 128-134, vol. 19-No. 3, Department of Orthopaedic Surgery, Hiroshima University School of Medicine, Hiroshima, Japan.
William G. Kussmaul III MD, et al., Rapid arterial hemostasis and decreased access site complications after cardiac catheterization and angioplasty: Results of a randomized trial of a novel hemostatic device, Journal of the American College of Cardiology, Jun. 1995, pp. 1685-1692, vol. 25—No. 7.
U.S. Appl. No. 09/478,179, Nov. 6, 2000, Notice of Allowance.
U.S. Appl. No. 09/546,998, May 6, 2002, Notice of Allowance.
U.S. Appl. No. 09/610,238, Mar. 26, 2001, Notice of Allowance.
U.S. Appl. No. 09/610,238, Sep. 5, 2001, Office Action.
U.S. Appl. No. 09/610,238, Feb. 11, 2002, Notice of Allowance.
U.S. Appl. No. 09/680,837, Jul. 9, 2002, Office Action.
U.S. Appl. No. 09/680,837, Nov. 6, 2002, Office Action.
U.S. Appl. No. 09/680,837, Mar. 25, 2003, Office Action.
U.S. Appl. No. 09/680,837, Jun. 16, 2003, Notice of Allowance.
U.S. Appl. No. 09/732,178, Aug. 1, 2002, Office Action.
U.S. Appl. No. 09/732,178, Dec. 24, 2002 Office Action.
U.S. Appl. No. 09/732,178, Jun. 10, 2003, Office Action.
U.S. Appl. No. 09/732,178, Jul. 3, 2003, Office Action.
U.S. Appl. No. 09/732,178, Nov. 17, 2003, Notice of Allowance.
U.S. Appl. No. 09/732,835, Sep. 11, 2003, Office Action.
U.S. Appl. No. 09/732,835, Feb. 9, 2004, Office Action.
U.S. Appl. No. 09/732,835, Mar. 17, 2004, Notice of Allowance.
U.S. Appl. No. 09/764,813, Mar. 26, 2001, Office Action.
U.S. Appl. No. 09/764,813, Jun. 4, 2001, Notice of Allowance.
U.S. Appl. No. 09/933,299, Feb. 26, 2003, Office Action.
U.S. Appl. No. 09/933,299, Jun. 16, 2003, Notice of Allowance.
U.S. Appl. No. 09/948,813, Jan. 31, 2003, Notice of Allowance.
U.S. Appl. No. 09/949,398, Mar. 4, 2003, Office Action.
U.S. Appl. No. 09/949,398, Jul. 28, 2003, Notice of Allowance.
U.S. Appl. No. 09/949,438, Dec. 17, 2002, Office Action.
U.S. Appl. No. 09/949,438, Apr. 21, 2003, Notice of Allowance.
U.S. Appl. No. 10/006,400, Aug. 27, 2004, Office Action.
U.S. Appl. No. 10/006,400, Feb. 23, 2005 Office Action.
U.S. Appl. No. 10/006,400, Apr. 11, 2005, Office Action.
U.S. Appl. No. 10/006,400, Jul. 27, 2005, Office Action.
U.S. Appl. No. 10/006,400, Mar. 6, 2006, Office Action.
U.S. Appl. No. 10/006,400, May 24, 2006, Office Action.
U.S. Appl. No. 10/006,400, Oct. 26, 2006 Office Action.
U.S. Appl. No. 10/006,400, Apr. 19, 2007, Office Action.
U.S. Appl. No. 10/006,400, Apr. 2, 2008, Office Action.
U.S. Appl. No. 10/006,400, Jan. 2, 2009, Office Action.
U.S. Appl. No. 10/006,400, Jul. 9, 2009, Notice of Allowance.
U.S. Appl. No. 10/006,400, Jan. 13, 2010, Notice of Allowance.
U.S. Appl. No. 10/006,400, Apr. 27, 2010, Notice of Allowance.
U.S. Appl. No. 10/006,400, Aug. 2, 2010, Notice of Allowance.
U.S. Appl. No. 10/081,717, Sep. 29, 2003, Notice of Allowance.
U.S. Appl. No. 10/081,723, Sep. 29, 2004, Office Action.
U.S. Appl. No. 10/081,723, May 13, 2005, Notice of Allowance.
U.S. Appl. No. 10/081,725, Feb. 9, 2004, Notice of Allowance.
U.S. Appl. No. 10/081,725, Apr. 13, 2004, Office Action.
U.S. Appl. No. 10/081,726, Apr. 11, 2003, Notice of Allowance.
U.S. Appl. No. 10/081,726, Jun. 9, 2003, Notice of Allowance.
U.S. Appl. No. 10/147,774, Nov. 4, 2004, Office Action.
U.S. Appl. No. 10/147,774, May 4, 2005, Office Action.
U.S. Appl. No. 10/147,774, Oct. 18, 2005, Office Action.
U.S. Appl. No. 10/147,774, Apr. 18, 2007, Notice of Allowance.
U.S. Appl. No. 10/147,774, Sep. 27, 2007, Notice of Allowance.
U.S. Appl. No. 10/147,774, Feb. 4, 2008, Notice of Allowance.
U.S. Appl. No. 10/147,774, Jun. 30, 2008, Office Action.
U.S. Appl. No. 10/147,774, Mar. 18, 2009, Office Action.
U.S. Appl. No. 10/147,774, Oct. 26, 2009, Office Action.
U.S. Appl. No. 10/147,774, Jun. 8, 2010, Office Action.
U.S. Appl. No. 10/147,774, Dec. 2, 2010, Notice of Allowance.
U.S. Appl. No. 10/240,183, Jul. 27, 2004, Office Action.
U.S. Appl. No. 10/240,183, Dec. 17, 2004, Office Action.
U.S. Appl. No. 10/240,183, Mar. 9, 2005, Notice of Allowance.
U.S. Appl. No. 10/240,183, Aug. 11, 2006, Office Action.
U.S. Appl. No. 10/264,306, Feb. 9, 2005, Office Action.
U.S. Appl. No. 10/264,306, Oct. 4, 2005, Office Action.
U.S. Appl. No. 10/264,306, May 10, 2006, Notice of Allowance.
U.S. Appl. No. 10/264,306, Jul. 2, 2007, Notice of Allowance.
U.S. Appl. No. 10/264,306, Feb. 4, 2008, Notice of Allowance.
U.S. Appl. No. 10/264,306, Jun. 27, 2008, Office Action.
U.S. Appl. No. 10/264,306, Feb. 26, 2009, Office Action.
U.S. Appl. No. 10/264,306, Aug. 13, 2009, Office Action.
U.S. Appl. No. 10/264,306, Jan. 27, 2010, Office Action.
U.S. Appl. No. 10/264,306, Jun. 15, 2010, Office Action.
U.S. Appl. No. 10/264,306, Oct. 29, 2010, Notice of Allowance.
U.S. Appl. No. 10/335,075, Aug. 10, 2005, Office Action.
U.S. Appl. No. 10/335,075, Dec. 19, 2005, Office Action.
U.S. Appl. No. 10/335,075, Apr. 21, 2006, Office Action.
U.S. Appl. No. 10/335,075, Dec. 27, 2006, Notice of Allowance.
U.S. Appl. No. 10/356,214, Nov. 30, 2005, Office Action.
U.S. Appl. No. 10/356,214, Aug. 23, 2006, Office Action.
U.S. Appl. No. 10/356,214, Feb. 13, 2007, Office Action.
U.S. Appl. No. 10/356,214, Sep. 12, 2007, Office Action.
U.S. Appl. No. 10/356,214, Mar. 6, 2008, Office Action.
U.S. Appl. No. 10/356,214, Nov. 4, 2008, Office Action.
U.S. Appl. No. 10/356,214, Apr. 29, 2009, Office Action.
U.S. Appl. No. 10/356,214, Jan. 13, 2010, Notice of Allowance.
U.S. Appl. No. 10/356,214, May 13, 2010, Notice of Allowance.
U.S. Appl. No. 10/356,214, Sep. 3, 2010, Notice of Allowance.
U.S. Appl. No. 10/435,104, Jun. 10, 2004, Office Action.
U.S. Appl. No. 10/435,104, Sep. 21, 2004, Notice of Allowance.
U.S. Appl. No. 10/435,104, Jan. 3, 2006, Examiners Amendment.
U.S. Appl. No. 10/435,104, May 16, 2006, Office Action.
U.S. Appl. No. 10/435,104, Dec. 28, 2006, Notice of Allowance.
U.S. Appl. No. 10/435,104, Jul. 10, 2007, Notice of Allowance.
U.S. Appl. No. 10/435,104, Aug. 2, 2007, Notice of Allowance.
U.S. Appl. No. 10/435,104, Oct. 26, 2007, Notice of Allowance.
U.S. Appl. No. 10/435,104, Nov. 14, 2007, Notice of Allowance.
U.S. Appl. No. 10/435,104, Apr. 4, 2008, Notice of Allowance.
U.S. Appl. No. 10/435,104, Sep. 26, 2008, Notice of Allowance.
U.S. Appl. No. 10/435,104, Dec. 22, 2008, Notice of Allowance.
U.S. Appl. No. 10/435,104, Jul. 23, 2009, Notice of Allowance.
U.S. Appl. No. 10/435,104, Jan. 20, 2010, Notice of Allowance.
U.S. Appl. No. 10/435,104, Jun. 2, 2010, Office Action.
U.S. Appl. No. 10/435,104, Oct. 5, 2010, Notice of Allowance.
U.S. Appl. No. 10/455,768, Nov. 16, 2004, Office Action.
U.S. Appl. No. 10/455,768, Apr. 6, 2005, Notice of Allowance.
U.S. Appl. No. 10/486,067, Jan. 10, 2006, Office Action.
U.S. Appl. No. 10/486,067, Sep. 20, 2006, Notice of Allowance.
U.S. Appl. No. 10/486,070, Apr. 20, 2005, Office Action.
U.S. Appl. No. 10/486,070, Aug. 10, 2005, Office Action.
U.S. Appl. No. 10/486,070, Oct. 18, 2005, Notice of Allowance.
U.S. Appl. No. 10/517,004, Aug. 13, 2007, Office Action.
U.S. Appl. No. 10/517,004, Jan. 30, 2008, Office Action.
U.S. Appl. No. 10/517,004, Aug. 13, 2008, Notice of Allowance.
U.S. Appl. No. 10/517,004, Feb. 10, 2009, Notice of Allowance.
U.S. Appl. No. 10/517,004, Mar. 24, 2009, Notice of Allowance.
U.S. Appl. No. 10/517,004, Jun. 26, 2009, Notice of Allowance.
U.S. Appl. No. 10/517,004, Jan. 11, 2010, Notice of Allowance.
U.S. Appl. No. 10/517,004, Apr. 23, 2010, Notice of Allowance.
U.S. Appl. No. 10/517,004, Aug. 3, 2010, Notice of Allowance.
U.S. Appl. No. 10/517,004, Nov. 23, 2010, Issue Notification.
U.S. Appl. No. 10/519,778, Feb. 23, 2006, Office Action.
U.S. Appl. No. 10/519,778, May 31, 2006, Notice of Allowance.
U.S. Appl. No. 10/541,083, Oct. 16, 2007, Office Action.
U.S. Appl. No. 10/541,083, Oct. 31, 2007, Office Action.
U.S. Appl. No. 10/541,083, May 5, 2008, Office Action.
U.S. Appl. No. 10/541,083, Sep. 19, 2008, Notice of Allowance.
U.S. Appl. No. 10/541,083, Dec. 29, 2008, Notice of Allowance.
U.S. Appl. No. 10/541,083, Apr. 16, 2009, Notice of Allowance.
U.S. Appl. No. 10/541,083, Sep. 30, 2009, Notice of Allowance.
U.S. Appl. No. 10/541,083, Feb. 5, 2010, Notice of Allowance.
U.S. Appl. No. 10/541,083, May 10, 2010, Notice of Allowance.
U.S. Appl. No. 10/541,083, Aug. 17, 2010, Notice of Allowance.
U.S. Appl. No. 10/541,083, Dec. 1, 2010, Issue Notification.
U.S. Appl. No. 10/616,832, Jun. 30, 2006, Office Action.
U.S. Appl. No. 10/616,832, Oct. 20, 2006, Office Action.
U.S. Appl. No. 10/616,832, May 29, 2007, Office Action.
U.S. Appl. No. 10/616,832, Jan. 22, 2008, Office Action.
U.S. Appl. No. 10/616,832, Sep. 17, 2008, Office Action.
U.S. Appl. No. 10/616,832, Jul. 21, 2009, Office Action.
U.S. Appl. No. 10/616,832, Jan. 11, 2010, Notice of Allowance.
U.S. Appl. No. 10/616,832, May 12, 2010, Notice of Allowance.
U.S. Appl. No. 10/616,832, Sep. 20, 2010, Notice of Allowance.
U.S. Appl. No. 10/617,090, Mar. 22, 2005, Office Action.
U.S. Appl. No. 10/617,090, Jul. 6, 2005, Notice of Allowance.
U.S. Appl. No. 10/617,090, Oct. 5, 2005, Notice of Allowance.
U.S. Appl. No. 10/638,115, Sep. 22, 2006, Restriction Requirement.
U.S. Appl. No. 10/638,115, Jan. 31, 2007, Office Action.
U.S. Appl. No. 10/638,115, Sep. 18, 2007, Office Action.
U.S. Appl. No. 10/638,115, Feb. 7, 2008, Office Action.
U.S. Appl. No. 10/638,115, Oct. 29, 2008, Office Action.
U.S. Appl. No. 10/638,115, May 7, 2009, Notice of Allowance.
U.S. Appl. No. 10/638,115, Dec. 1, 2009, Notice of Allowance.
U.S. Appl. No. 10/638,115, Apr. 2, 2010, Notice of Allowance.
U.S. Appl. No. 10/638,115, Aug. 13, 2010, Notice of Allowance.
U.S. Appl. No. 10/638,115, Dec. 22, 2010, Issue Notification.
U.S. Appl. No. 10/667,144, Sep. 19, 2006, Office Action.
U.S. Appl. No. 10/667,144, May 2, 2007, Office Action.
U.S. Appl. No. 10/667,144, Nov. 19, 2007, Office Action.
U.S. Appl. No. 10/667,144, Dec. 5, 2007, Office Action.
U.S. Appl. No. 10/667,144, May 12, 2008, Office Action.
U.S. Appl. No. 10/667,144, Mar. 24, 2009, Office Action.
U.S. Appl. No. 10/667,144, Nov. 23, 2009, Office Action.
U.S. Appl. No. 10/667,144, Jun. 22, 2010, Office Action.
U.S. Appl. No. 10/667,144, Jun. 6, 2011, Office Action.
U.S. Appl. No. 10/667,144, Oct. 28, 2011, Notice of Allowance.
U.S. Appl. No. 10/669,313, Oct. 31, 2005, Office Action.
U.S. Appl. No. 10/669,313, Jan. 11, 2006, Notice of Allowance.
U.S. Appl. No. 10/669,313, Jun. 28, 2006, Notice of Allowance.
U.S. Appl. No. 10/682,459, Sep. 15, 2006, Office Action.
U.S. Appl. No. 10/682,459, Apr. 18, 2007, Office Action.
U.S. Appl. No. 10/682,459, Apr. 2, 2008, Office Action.
U.S. Appl. No. 10/682,459, Dec. 4, 2008, Office Action.
U.S. Appl. No. 10/682,459, Jun. 10, 2009, Office Action.
U.S. Appl. No. 10/682,459, Dec. 23, 2009, Office Action.
U.S. Appl. No. 10/682,459, Apr. 28, 2010, Office Action.
U.S. Appl. No. 10/682,459, Oct. 12, 2010, Office Action.
U.S. Appl. No. 10/682,459, Apr. 1, 2011, Notice of Allowance.
U.S. Appl. No. 10/786,444, Oct. 30, 2006, Office Action.
U.S. Appl. No. 10/786,444, Apr. 17, 2007, Office Action.
U.S. Appl. No. 10/786,444, Aug. 31, 2007, Office Action.
U.S. Appl. No. 10/786,444, Apr. 24, 2008, Office Action.
U.S. Appl. No. 10/786,444, Oct. 17, 2008, Office Action.
U.S. Appl. No. 10/786,444, Jun. 18, 2009, Office Action.
U.S. Appl. No. 10/786,444, Jan. 14, 2010, Office Action.
U.S. Appl. No. 10/787,073, Nov. 30, 2006, Office Action.
U.S. Appl. No. 10/787,073, Sep. 5, 2007, Office Action.
U.S. Appl. No. 10/787,073, Feb. 22, 2008, Office Action.
U.S. Appl. No. 10/787,073, Nov. 12, 2008, Office Action.
U.S. Appl. No. 10/787,073, Aug. 13, 2009, Office Action.
U.S. Appl. No. 10/787,073, Feb. 17, 2010, Notice of Allowance.
U.S. Appl. No. 10/787,073, Aug. 25, 2010, Notice of Allowance.
U.S. Appl. No. 10/787,073, Sep. 15, 2010, Issue Notification.
U.S. Appl. No. 10/908,721, Oct. 19, 2006, Office Action.
U.S. Appl. No. 10/908,721, Aug. 10, 2007, Office Action.
U.S. Appl. No. 10/908,721, Jan. 25, 2008, Office Action.
U.S. Appl. No. 10/908,721, Nov. 25, 2008, Office Action.
U.S. Appl. No. 10/908,721, Jun. 23, 2009, Office Action.
U.S. Appl. No. 10/908,721, Feb. 2, 2010, Office Action.
U.S. Appl. No. 11/048,503, Mar. 13, 2009, Office Action.
U.S. Appl. No. 11/048,503, Jun. 26, 2009, Office Action.
U.S. Appl. No. 11/048,503, Jan. 11, 2010, Notice of Allowance.
U.S. Appl. No. 11/048,503, Apr. 26, 2010, Notice of Allowance.
U.S. Appl. No. 11/048,503, Jul. 30, 2010, Notice of Allowance.
U.S. Appl. No. 11/048,503, Dec. 8, 2010, Issue Notification.
U.S. Appl. No. 11/113,549, Feb. 6, 2007, Office Action.
U.S. Appl. No. 11/113,549, May 30, 2007, Office Action.
U.S. Appl. No. 11/113,549, Nov. 9, 2007, Office Action.
U.S. Appl. No. 11/113,549, Apr. 16, 2008, Office Action.
U.S. Appl. No. 11/113,549, Jul. 21, 2009, Office Action.
U.S. Appl. No. 11/113,549, Jul. 6, 2010, Office Action.
U.S. Appl. No. 11/113,549, Jan. 4, 2011, Office Action.
U.S. Appl. No. 11/152,562, May 13, 2008, Office Action.
U.S. Appl. No. 11/152,562, Feb. 13, 2009, Office Action.
U.S. Appl. No. 11/152,562, Jul. 6, 2009, Office Action.
U.S. Appl. No. 11/152,562, Mar. 31, 2010, Office Action.
U.S. Appl. No. 11/152,562, Sep. 16, 2010, Notice of Allowance.
U.S. Appl. No. 11/198,811, Aug. 26, 2008, Office Action.
U.S. Appl. No. 11/198,811, Apr. 6, 2009, Office Action.
U.S. Appl. No. 11/198,811, Sep. 22, 2009, Office Action.
U.S. Appl. No. 11/198,811, Jun. 29, 2010, Notice of Allowance.
U.S. Appl. No. 11/198,811, Oct. 20, 2010, Issue Notification.
U.S. Appl. No. 11/344,793, Jan. 22, 2009, Office Action.
U.S. Appl. No. 11/344,868, Mar. 25, 2009, Office Action.
U.S. Appl. No. 11/344,891, Apr. 29, 2008, Office Action.
U.S. Appl. No. 11/344,891, Dec. 8, 2008, Office Action.
U.S. Appl. No. 11/344,891, Feb. 26, 2009, Office Action.
U.S. Appl. No. 11/344,891, Oct. 7, 2009, Office Action.
U.S. Appl. No. 11/344,891, May 7, 2010, Office Action.
U.S. Appl. No. 11/390,586, Jun. 24, 2009, Office Action.
U.S. Appl. No. 11/390,586, Jul. 6, 2010, Office Action.
U.S. Appl. No. 11/396,141, May 22, 2009, Restriction Requirement.
U.S. Appl. No. 11/396,141, Aug. 26, 2009, Office Action.
U.S. Appl. No. 11/396,141, May 4, 2010, Office Action.
U.S. Appl. No. 11/396,731, Feb. 13, 2009, Office Action.
U.S. Appl. No. 11/396,731, May 22, 2009, Office Action.
U.S. Appl. No. 11/396,731, Jun. 29, 2010, Office Action.
U.S. Appl. No. 11/396,731, Mar. 22, 2011, Office Action.
U.S. Appl. No. 11/396,731, Sep. 1, 2011, Office Action.
U.S. Appl. No. 11/406,203, May 14, 2007, Office Action.
U.S. Appl. No. 11/406,203, Jan. 29, 2008, Notice of Allowance.
U.S. Appl. No. 11/406,203, May 23, 2008, Notice of Allowance.
U.S. Appl. No. 11/406,203, Sep. 22, 2008, Notice of Allowance.
U.S. Appl. No. 11/406,203, Mar. 3, 2009, Office Action.
U.S. Appl. No. 11/406,203, Sep. 16, 2009, Office Action.
U.S. Appl. No. 11/406,203, Jun. 18, 2010, Notice of Allowance.
U.S. Appl. No. 11/406,203, Oct. 6, 2010, Issue Notification.
U.S. Appl. No. 11/411,925, Jun. 6, 2007, Office Action.
U.S. Appl. No. 11/411,925, Feb. 5, 2008, Office Action.
U.S. Appl. No. 11/411,925, Jan. 12, 2009, Office Action.
U.S. Appl. No. 11/411,925, Sep. 10, 2009, Office Action.
U.S. Appl. No. 11/427,297, Jan. 30, 2009, Office Action.
U.S. Appl. No. 11/427,297, Sep. 15, 2009, Office Action.
U.S. Appl. No. 11/427,297, Sep. 15, 2010, Office Action.
U.S. Appl. No. 11/427,297, Mar. 21, 2011, Office Action.
U.S. Appl. No. 11/427,309, May 28, 2008, Restriction Requirement.
U.S. Appl. No. 11/427,309, Jan. 2, 2009, Office Action.
U.S. Appl. No. 11/427,309, Apr. 20, 2009, Office Action.
U.S. Appl. No. 11/427,309, Nov. 6, 2009, Office Action.
U.S. Appl. No. 11/427,309, Apr. 26, 2010, Office Action.
U.S. Appl. No. 11/427,309, Nov. 15, 2010, Office Action.
U.S. Appl. No. 11/455,993, Feb. 17, 2009, Office Action.
U.S. Appl. No. 11/455,993, Dec. 16, 2009, Office Action.
U.S. Appl. No. 11/532,325, Feb. 23, 2009, Office Action.
U.S. Appl. No. 11/532,325, Jun. 17, 2009, Office Action.
U.S. Appl. No. 11/532,325, Jan. 5, 2010, Office Action.
U.S. Appl. No. 11/532,576, Mar. 1, 2010, Restriction Requirement.
U.S. Appl. No. 11/532,576, Apr. 23, 2010, Office Action.
U.S. Appl. No. 11/532,576, Oct. 13, 2010, Notice of Allowance.
U.S. Appl. No. 11/674,930, Jan. 8, 2009, Office Action.
U.S. Appl. No. 11/674,930, Jun. 4, 2009, Office Action.
U.S. Appl. No. 11/674,930, Jan. 8, 2010, Office Action.
U.S. Appl. No. 11/675,462, Dec. 10, 2009, Office Action.
U.S. Appl. No. 11/675,462, Aug. 31, 2010, Office Action.
U.S. Appl. No. 11/675,462, Aug. 3, 2011, Office Action.
U.S. Appl. No. 11/675,462, Dec. 22, 2011, Notice of Allowance.
U.S. Appl. No. 11/744,089, Nov. 26, 2008, Office Action.
U.S. Appl. No. 11/744,089, Aug. 14, 2009, Office Action.
U.S. Appl. No. 11/757,108, Nov. 25, 2009, Restriction Requirement.
U.S. Appl. No. 11/767,818, Dec. 24, 2009, Restriction Requirement.
U.S. Appl. No. 11/767,818, Mar. 22, 2010, Office Action.
U.S. Appl. No. 11/767,818, Sep. 30, 2010, Office Action.
U.S. Appl. No. 11/767,818, Feb. 16, 2011, Office Action.
U.S. Appl. No. 11/852,190, Jun. 24, 2010, Restriction Requirement.
U.S. Appl. No. 11/852,190, Nov. 1, 2010, Office Action.
U.S. Appl. No. 11/852,190, Mar. 2, 2011, Office Action.
U.S. Appl. No. 11/958,281, Sep. 2, 2010, Restriction Requirement.
U.S. Appl. No. 11/958,281, Oct. 8, 2010, Office Action.
U.S. Appl. No. 11/958,281, Mar. 10, 2011, Office Action.
U.S. Appl. No. 11/958,295, Aug. 27, 2009, Office Action.
U.S. Appl. No. 11/958,295, May 25, 2010, Office Action.
U.S. Appl. No. 11/959,334, Aug. 19, 2009, Office Action.
U.S. Appl. No. 11/959,334, Jan. 12, 2010, Notice of Allowance.
U.S. Appl. No. 11/959,334, Apr. 14, 2010, Notice of Allowance.
U.S. Appl. No. 11/959,334, Jul. 23, 2010, Notice of Allowance.
U.S. Appl. No. 11/959,334, Nov. 10, 2010, Issue Notification.
U.S. Appl. No. 12/106,928, Jan. 23, 2009, Office Action.
U.S. Appl. No. 12/106,928, Oct. 5, 2009, Office Action.
U.S. Appl. No. 12/106,928, May 10, 2010, Office Action.
U.S. Appl. No. 12/106,928, Oct. 25, 2010, Office Action.
U.S. Appl. No. 12/106,937, Mar. 30, 2009, Office Action.
U.S. Appl. No. 12/106,937, Nov. 18, 2009, Office Action.
U.S. Appl. No. 12/113,851, Apr. 27, 2010, Restriction Requirement.
U.S. Appl. No. 12/113,851, Jun. 24, 2010, Office Action.
U.S. Appl. No. 12/113,851, Dec. 16, 2010, Office Action.
U.S. Appl. No. 12/113,851, Apr. 27, 2011, Office Action.
U.S. Appl. No. 12/114,031, Oct. 5, 2010, Restriction Requirement.
U.S. Appl. No. 12/114,031, Nov. 22, 2010, Office Action.
U.S. Appl. No. 12/114,031, May 11, 2011, Office Action.
U.S. Appl. No. 12/114,031, Aug. 2, 2011, Office Action.
U.S. Appl. No. 12/114,091, Oct. 27, 2010, Restriction Requirement.
U.S. Appl. No. 12/114,091, Dec. 17, 2010, Office Action.
U.S. Appl. No. 12/114,091, Jul. 7, 2011, Office Action.
U.S. Appl. No. 12/122,603, Mar. 3, 2011, Office Action.
U.S. Appl. No. 12/122,603, Apr. 22, 2011, Office Action.
U.S. Appl. No. 12/122,603, Sep. 23, 2011, Office Action.
U.S. Appl. No. 12/135,858, Jul. 13, 2011, Office Action.
U.S. Appl. No. 12/143,020, May 11, 2011, Restriction Requirement.
U.S. Appl. No. 12/143,020, Aug. 31, 2011, Office Action.
U.S. Appl. No. 12/393,877, Sep. 29, 2011, Office Action.
U.S. Appl. No. 12/393,877, Dec. 13, 2011, Office Action.
U.S. Appl. No. 12/402,398, Mar. 9, 2010, Restriction Requirement.
U.S. Appl. No. 12/402,398, May 20, 2010, Office Action.
U.S. Appl. No. 12/402,398, Jan. 24, 2011, Office Action.
U.S. Appl. No. 12/403,256, Dec. 16, 2009, Restriction Requirement.
U.S. Appl. No. 12/403,256, Mar. 30, 2010, Office Action.
U.S. Appl. No. 12/403,256, Aug. 19, 2010, Notice of Allowance.
U.S. Appl. No. 12/403,277, Jul. 8, 2010, Restriction Requirement.
U.S. Appl. No. 12/403,277, Oct. 12, 2010, Office Action.
U.S. Appl. No. 12/403,277, Mar. 31, 2011, Office Action.
U.S. Appl. No. 12/481,377, Apr. 28, 2011, Restriction Requirement.
U.S. Appl. No. 12/481,377, Jun. 21, 2011, Office Action.
U.S. Appl. No. 12/481,377, Jan. 3, 2012, Office Action.
U.S. Appl. No. 12/548,274, Dec. 28, 2011, Restriction Requirement.
U.S. Appl. No. 12/684,470, Dec. 20, 2011, Restriction Requirement.
U.S. Appl. No. 12/684,562, Dec. 28, 2011, Restriction Requirement.
U.S. Appl. No. 12/684,569, Dec. 20, 2011, Restriction Requirement.
U.S. Appl. No. 12/897,358, Aug. 22, 2011, Office Action.
U.S. Appl. No. 12/941,809, Dec. 13, 2011, Restriction Requirement.
U.S. Appl. No. 12/945,646, Jan. 20, 2011, Office Action.
U.S. Appl. No. 12/945,646, Jul. 6, 2011, Office Action.
U.S. Appl. No. 12/945,646, Oct. 26, 2011, Office Action.
U.S. Appl. No. 12/955,859, May 26, 2011, Restriction Requirement.
U.S. Appl. No. 12/955,859, Jul. 21, 2011, Office Action.
U.S. Appl. No. 12/955,859, Dec. 15, 2011, Office Action.
U.S. Appl. No. 13/026,989, Sep. 16, 2011, Office Action.
U.S. Appl. No. 29/296,370, Aug. 18, 2008, Office Action.
U.S. Appl. No. 29/296,370, Dec. 2, 2008, Notice of Allowance.
U.S. Appl. No. 29/296,370, Apr. 1, 2009, Notice of Allowance.
U.S. Appl. No. 12/608,773, Jan. 7, 2013, Office Action.
U.S. Appl. No. 13/490,143, Jan. 4, 2013, Office Action.
U.S. Appl. No. 12/897,358, Jan. 12, 2012, Notice of Allowance.
Turn—macmilliandictionary.com/dictionary.american/turn.
Turn—Merriam-webster.com/dictionary/turn.
U.S. Appl. No. 11/113,549, Mar. 14, 2014, Notice of Allowance.
U.S. Appl. No. 11/396,141, Nov. 4, 2013, Notice of Allowance.
U.S. Appl. No. 11/396,141, Mar. 19, 2014, Issue Notification.
U.S. Appl. No. 11/411,925, Oct. 1, 2013, Office Action.
U.S. Appl. No. 11/411,925, Feb. 5, 2014, Notice of Allowance.
U.S. Appl. No. 11/455,993, Jan. 29, 2014, Office Action.
U.S. Appl. No. 11/532,325, Dec. 2, 2013, Office Action.
U.S. Appl. No. 11/674,930, Apr. 3, 2014, Notice of Allowance.
U.S. Appl. No. 11/852,190, Nov. 26, 2013, Office Action.
U.S. Appl. No. 11/852,190, Feb. 12, 2014, Notice of Allowance.
U.S. Appl. No. 12/106,928, Dec. 2, 2013, Office Action.
U.S. Appl. No. 12/106,928, Mar. 25, 2014, Advisory Action.
U.S. Appl. No. 12/106,937, Jan. 22, 2014, Office Action.
U.S. Appl. No. 12/113,851, Mar. 17, 2014, Office Action.
U.S. Appl. No. 12/114,031, Mar. 10, 2014, Office Action.
U.S. Appl. No. 12/122,603, Nov. 20, 2013, Office Action.
U.S. Appl. No. 12/403,277, Jan. 27, 2014, Office Action.
U.S. Appl. No. 12/642,319, Dec. 16, 2013, Office Action.
U.S. Appl. No. 12/688,065, Oct. 18, 2013, Office Action.
U.S. Appl. No. 12/688,065, Apr. 8, 2014, Office Action.
U.S. Appl. No. 12/848,642, Feb. 3, 2014, Notice of Allowance.
U.S. Appl. No. 12/941,809, Nov. 8, 2013, Office Action.
U.S. Appl. No. 12/941,809, Feb. 3, 2014, Notice of Allowance.
U.S. Appl. No. 12/961,331, Sep. 20, 2013, Advisory Action.
U.S. Appl. No. 12/987,792, Jan. 21, 2014, Office Action.
U.S. Appl. No. 13/030,922, Jan. 8, 2014, Notice of Allowance.
U.S. Appl. No. 13/112,618, Nov. 20, 2013, Office Action.
U.S. Appl. No. 13/112,631, Dec. 2, 2013, Office Action.
U.S. Appl. No. 13/153,594, Oct. 16, 2013, Notice of Allowance.
U.S. Appl. No. 13/308,227, Sep. 11, 2013, Office Action.
U.S. Appl. No. 13/791,829, Oct. 8, 2013, Notice of Allowance.
U.S. Appl. No. 13/898,202, Jan. 3, 2014, Office Action.
U.S. Appl. No. 14/246,926, filed Apr. 7, 2014, Carley et al.
U.S. Appl. No. 14/246,973, filed Apr. 1, 2014, Carley et al.
U.S. Appl. No. 14/323,753, filed Jul. 3, 2014, Forston et al.
U.S. Appl. No. 11/113,549, Jul. 2, 2014, Issue Notification.
U.S. Appl. No. 11/411,925, Jun. 4, 2014, Issue Notification.
U.S. Appl. No. 11/852,190, Jun. 4, 2014, Issue Notification.
U.S. Appl. No. 11/958,295, Jun. 13, 2014, Notice of Allowance.
U.S. Appl. No. 12/122,603, Apr. 30, 2014, Office Action.
U.S. Appl. No. 12/608,773, Jul. 17, 2014, Office Action.
U.S. Appl. No. 12/642,319, May 27, 2014, Notice of Allowance.
U.S. Appl. No. 12/684,470, Jun. 4, 2014, Office Action.
U.S. Appl. No. 12/684,542, Jun. 18, 2014, Office Action.
U.S. Appl. No. 12/684,569, Apr. 23, 2014, Office Action.
U.S. Appl. No. 12/848,642, Jun. 4, 2014, Issue Notification.
U.S. Appl. No. 12/941,809, Jun. 4, 2014, Issue Notification.
U.S. Appl. No. 12/950,628, Apr. 25, 2014, Notice of Allowance.
U.S. Appl. No. 12/961,331, Apr. 25, 2014, Notice of Allowance.
U.S. Appl. No. 12/987,792, Jun. 11, 2014, Office Action.
U.S. Appl. No. 14/466,576, filed Aug. 22, 2014, Roorda et al.
U.S. Appl. No. 14/539,830, filed Nov. 12, 2014, Clark.
U.S. Appl. No. 11/455,993, Aug. 11, 2014, Notice of Allowance.
U.S. Appl. No. 11/958,295, Nov. 5, 2014, Issue Notification.
U.S. Appl. No. 12/106,928, Oct. 3, 2014, Notice of Allowance.
U.S. Appl. No. 12/113,851, Aug. 21, 2014, Office Action.
U.S. Appl. No. 12/393,877, Aug. 4, 2014, Notice of Allowance.
U.S. Appl. No. 12/393,877, Nov. 19, 2014, Issue Notification.
U.S. Appl. No. 12/403,277, Aug. 15, 2014, Office Action.
U.S. Appl. No. 12/548,274, Aug. 14, 2014, Office Action.
U.S. Appl. No. 12/642,319, Sep. 24, 2014, Issue Notification.
U.S. Appl. No. 12/684,470, Nov. 14, 2014, Office Action.
U.S. Appl. No. 12/684,562, Sep. 10, 2014, Office Action.
U.S. Appl. No. 12/987,792, Aug. 25, 2014, Notice of Allowance.
U.S. Appl. No. 13/112,631, Nov. 20, 2014, Office Action.
U.S. Appl. No. 13/898,202, Aug. 21, 2014, Office Action.
U.S. Appl. No. 14/562,467, filed Dec. 5, 2014, Ellingwood et al.
U.S. Appl. No. 11/396,731, Feb. 12, 2015, Office Action.
U.S. Appl. No. 11/532,325, Jan. 16, 2015, Notice of Allowance.
U.S. Appl. No. 12/106,937, Mar. 5, 2015, Notice of Allowance.
U.S. Appl. No. 12/113,851, Feb. 20, 2015, Notice of Allowance.
U.S. Appl. No. 12/114,091, Feb. 12, 2015, Office Action.
U.S. Appl. No. 12/608,773, Mar. 12, 2015, Office Action.
U.S. Appl. No. 12/684,400, Feb. 23, 2015, Office Action.
U.S. Appl. No. 12/684,542, Dec. 1, 2014, Office Action.
U.S. Appl. No. 12/684,562, Feb. 17, 2015, Notice of Allowance.
U.S. Appl. No. 13/112,618, Dec. 15, 2014, Office Action.
U.S. Appl. No. 13/898,202, Feb. 10, 2015, Notice of Allowance.
U.S. Appl. No. 14/017,039, Jan. 23, 2015, Office Action.
U.S. Appl. No. 12/106,937, May 20, 2015, Issue Notification.
U.S. Appl. No. 12/113,851, Jun. 3, 2015, Issue Notification.
U.S. Appl. No. 12/122,603, Apr. 9, 2015, Office Action.
U.S. Appl. No. 13/112,618, May 18, 2015, Office Action.
U.S. Appl. No. 13/112,631, Apr. 15, 2015, Office Action.
U.S. Appl. No. 13/791,846, Jun. 4, 2015, Office Action.
U.S. Appl. No. 13/898,202, May 20, 2015, Issue Notification.
U.S. Appl. No. 14/017,039, Jun. 10, 2015, Office Action.
U.S. Appl. No. 11/396,731, Jul. 9, 2015, Notice of Allowance.
U.S. Appl. No. 11/532,325, Jul. 8, 2015, Issue Notification.
U.S. Appl. No. 12/114,091, Jul. 23, 2015, Office Action.
U.S. Appl. No. 12/684,400, Jul. 28, 2015, Notice of Allowance.
U.S. Appl. No. 12/684,562, Jul. 8, 2015, Issue Notification.
U.S. Appl. No. 13/308,227, Jul. 14, 2015, Office Action.
U.S. Appl. No. 13/908,796, Jul. 21, 2015, Office Action.
U.S. Appl. No. 14/023,428, Jul. 27, 2015, Office Action.
U.S. Appl. No. 14/077,007, Jul. 27, 2015, Office Action.
U.S. Appl. No. 14/466,576, Jul. 8, 2015, Office Action.
U.S. Appl. No. 14/246,973, Aug. 3, 2015, Office Action.
U.S. Appl. No. 14/839,658, filed Aug. 31, 2015, Cummins et al.
U.S. Appl. No. 14/855,080, filed Sep. 15, 2015, Voss et al.
U.S. Appl. No. 12/122,603, Sep. 23, 2015, Notice of Allowance.
U.S. Appl. No. 12/608,773, Sep. 17, 2015, Notice of Allowance.
U.S. Appl. No. 12/684,470, Aug. 26, 2015, Office Action.
U.S. Appl. No. 13/791,846, Oct. 27, 2015, Notice of Allowance.
U.S. Appl. No. 14/017,039, Oct. 27, 2015, Office Action.
U.S. Appl. No. 14/246,926, Aug. 5, 2015, Office Action.
U.S. Appl. No. 14/323,753, Nov. 3, 2015, Office Action.
U.S. Appl. No. 12/684,470, filed Jan. 21, 2016, Office Action.
U.S. Appl. No. 13/791,846, filed Feb. 10, 2016, Issue Notification.
U.S. Appl. No. 14/077,007, filed Jan. 29, 2016, Office Action.
U.S. Appl. No. 14/312,339, filed Jan. 22, 2016, Office Action.
Carpenter et al, Midterm results of the multicenter trial of the Powerlink bifurcated system for endovascular aortic aneurysm repair, Journal of Vascular Surgery, vol. 40, No. 5, Nov. 2004, pp. 849-859.e5.
Eisenack et al, Percutaneous Endovascular Aortic Aneurysm Repair: A Prospective Evaluation of Safety, Efficiency, and Risk Factors, Journal of Endovascular Ther., 2009, vol. 16, pp. 708-713.
Greenhalgh et al, Endovascular versus open repair of abdominal aortic aneurysm, The New England journal of medicine, vol, 362, No. 20, 2010, pp. 1863-1871.
Grossman, W., Cardiac Catheterization and Angiography, 3rd Ed., Lea & Febiger, Philadelphia, pp. 1-49, 52-247. 1986.
Howell et al, Percutaneous Repair of Abdominal Aortic Aneurysms Using the aneuRx Stent Graft and the Percutaneous Vascular Surgery Device, Catheterization and cardiovascular interventions, vol. 55, No. 3, 2002, pp. 281-287.
Jean-Baptiste et al., Percutaneous closure devices for endovascular repair of infrarenal abdominal aortic aneurysms: a prospective, non-randomized comparative study, European Journal of Vascular and Endovascular Surgery, vol. 35, No. 4, 2008, pp. 422-428.
Krajcer and Gregoric, Totally percutaneous aortic aneurysm repair: methods and outcomes using the fully integrated IntuiTrak endovascular system, The Journal of cardiovascular surgery, vol. 51, No. 4, 2010, pp. 493-501.
Lederle et al, Outcomes following endovascular vs open repair of abdominal aortic aneurysm: a randomized trial, Jama, vol. 302, No. 14, 2009, pp, 1535-1542,.
Lee et al, Total percutaneous access for endovascular aortic aneurysm repair (“Predose” technique), Journal of vascular surgery, vol. 45, No. 6, 2007, pp. 1095-1101.
Malkawi et al, Percutaneous access for endovascular aneurysm repair: a systematic review, European Journal of Vascular and Endovascular Surgery, vol. 39, No. 6, 2010, pp. 676- 682.
Morasch et al, Percutaneous repair of abdominal aortic aneurysm, Journal of vascular surgery, vol. 40, No. 1, 2004, pp. 12-16.
Rachel et al, Percutaneous endovascular abdominal aortic aneurysm repair, Annals of vascular surgery, vol. 16, No. 1, 2002, pp. 43-49.
Starnes et al, Totally percutaneous aortic aneurysm repair: experience and prudence, Journal of vascular surgery, vol. 43, No. 2, 2006, pp. 270-276.
Teh et al, Use of the percutaneous vascular surgery device for closure of femoral access sites during endovascular aneurysrn repair: lessons from our experience, European Journal of Vascular and Endovascular Surgery, vol. 22, No. 5, 2001, pp. 418-423.
Torsello et al, Endovascular suture versus cutdown for endovascular aneurysm repair: a prospective randomized pilot study, Journal of vascular surgery, vol. 38, No. 1, 2003 pp. 78-82.
Traul et al, Percutaneous endovascular repair of infrarenal abdominal aortic aneurysms: a feasibility study, Journal of vascular surgery, vol. 32, No. 4, 2000, pp. 770-776.
Watelet et al, Percutaneous repair of aortic aneurysms: a prospective study of suture-mediated closure devices, European journal of vascular and endovascular surgery, vol. 32, No. 3, 2006, pp. 261-265.
U.S. Appl. No. 13/725,589, filed Sep. 17, 2015, Office Action.
U.S. Appl. No. 13/837,801, filed Dec. 16, 2015, Office Action.
U.S. Appl. No. 13/908,796, filed Nov. 6, 2015, Notice of Allowance.
U.S. Appl. No. 14/246,926, filed Nov. 23, 2015, Office Action.
U.S. Appl. No. 14/246,973, filed Nov. 24, 2015, Office Action.
U.S. Appl. No. 14/466,576, filed Dec. 15, 2015, Notice of Allowance.
Related Publications (1)
Number Date Country
20110313452 A1 Dec 2011 US
Continuations (2)
Number Date Country
Parent 10667144 Sep 2003 US
Child 13222899 US
Parent 10081726 Feb 2002 US
Child 10667144 US
Continuation in Parts (1)
Number Date Country
Parent 09732178 Dec 2000 US
Child 10081726 US